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1 Riassunto dell’attività svolta 
 
L’obbiettivo della tesi è stato rivolto all’ analisi del ruolo di OPA1 nella morte 
cellulare in vivo attraverso la caratterizzazione di un modello murino over-
esprimente OPA1 (Opa1tg) generato nel nostro laboratorio; in tale modello il 
transgene Opa1 è stato inserito in una specifica posizione del cromosoma X e sotto 
il controllo del promotore debole ed ubiquitario per la beta-actina umana. 
Attraverso l’incrocio dei topi in due diversi background genetici C57/BL6 e SV129,  
abbiamo ottenuto linee murine in cui OPA1 è debolmente espressa in diversi 
tessuti. Il lieve incremento dei livelli di OPA1 non altera le altre proteine coinvolte 
nella dinamica mitocondriale e non ha alcun effetto sullo sviluppo, la longevità e la 
fertilità degli animali.  Abbiamo osservato che la longevità dei topi Opa1tg C57/Bl6 
non mostrava variazioni rispetto ai wild type (WT), mentre era notevolmente 
ridotta negli  Opa1tg SV129, prevalentemente a causa di insorgenza di tumori 
ematologici e solidi.  Poiché i topi Opa1tg non mostravano alcun evidente fenotipo, 
abbiamo deciso di effettuare un analisi morfologica ed istologica in ogni organo. I 
cuori degli animali Opa1tg all’età di 9 mesi erano più grandi. Le analisi istologiche e 
di immunofluorescenza non rivelavano segni di ipertrofia e la funzionalità cardiaca 
era invece preservata come dimostrato dalle analisi ecocardiografiche, indicando 
che l’ipertrofia cardiaca osservata non era patologica e suggerendo altresì che 
l’atrofia cardiaca associata all’invecchiamento era inibita nei topi Opa1tg. 
Per verificare se l’over-espressione di Opa1 interferiva in qualche modo con 
l’atrofia associata al muscolo striato, abbiamo utilizzato un noto modello di atrofia 
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muscolare indotta tramite recisione del nervo sciatico. L’atrofia muscolare era 
significativamente ridotta nei topi Opa1tg, dove la funzionalità mitocondriale nelle 
fibre denervate era preservata. Questi risultati suggerivano che OPA1 può 
interferire con almeno una forma di danno cellulare in vivo e ci ha spinto a 
verificare se ciò potesse interferire anche in altri modelli conosciuti di morte 
cellulare quali necrosi ed apoptosi.  
In un modello di ischemia riperfusione di cuore isolato, i cuori Opa1tg erano meno 
suscettibili al danno ischemico e l’area d’infarto era significativamente ridotta nei 
topi Opa1tg  dopo il danno da ischemia cerebrale indotto tramite l’Occlusione 
dell’arteria Cerebrale Mediale (MCAo).  
In fine, l’apoptosi epatocellulare in vivo indotta da Fas era drasticamente ridotta in 
topi Opa1tg , dove il danno epatico era diminuito. Meccanisticamente, i mitocondri 
da muscolo e fagato dei Opa1tg topi sono risultati resistenti al rimodellamento 
delle cristae ed al rilascio di citocromo c indotto dalla proteina proapoptotica cBID; 
mostrano inoltre una aumentata efficienza nella respirazione mediata dal 
complesso I, mentre glia altri parametri di morte cellulare mediata dai mitocondri 
non sono risultati alterati.   L’aumento della respirazione dipendente da complesso 
I correla con un aumento dei Supercomplessi della Catena Respiratoria (RCS) che, 
come da noi dimostrato, è una conseguenza della stabilizzazione delle cristae 
dipendente da OPA1.   
I nostri dati dimostrano un ruolo della struttura delle cristae in diversi modelli di 
morte cellulare in vivo e comprovano un ruolo cruciale del rimodellamento 
7 
 
dell’ultrastruttura mitocondriale in risposta a diverse condizioni patologiche, che 
vanno dall’ischemia-riperfusione all’atrofia muscolare. Possiamo concludere che 
OPA1, la biogenesi ed il rimodellamento delle cristae sono processi fondamentali 
di danno reversibile ed irreversibile e di morte cellulare in vivo. 
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2 Summary 
Mitochondria are crucial organelles for cell life and death. They represent the site 
of oxidative phosphorylation which provides energy for cellular processes, and 
play key roles in Ca2+ signaling and integration and amplification of apoptotic 
signals. Mitochondria are double membrane organelles: they possess an outer 
mitochondrial membrane (OMM), and an inner mitochondrial membrane (IMM) 
that can be further subdivided in an inner ’’boundary membrane’’  and in the 
cristae which are compartments separated from the inner boundary membrane by 
narrow tubular junctions.  In addition mitochondria are highly dynamic and 
heterogeneous. Mitochondrial morphology and distribution are actively controlled 
to respond to the functional needs of the cell. This functional versatility is 
controlled by a growing family of ,,mitochondria-shaping’’ proteins that regulate 
fusion and fission events. In mammals mitochondrial fission depends on the 
cytoplasmic GTPase, dynamin related 1 (DRP1), and its adaptors on the outer 
mitochondrial membrane (OMM). Mitochondrial fusion is regulated by two OM 
proteins mitofusin 1and 2 (MFN1and MFN2), and Optic Atrophy 1 (OPA1) in the 
inner membrane (IM). OPA1 promotes mitochondrial fusion depending on MFN1 
and has an antiapoptotic function genetically distinguishable from its role in 
fission. OPA1 controls apoptotic cristae remodeling, a process required for the 
complete release of cytochrome c, the only soluble component of the respiratory 
chain. OPA1 oligomerizes in high molecular weight complexes, required for the 
maintenance of the cristae junction tight, thus preventing cytochrome c 
mobilization. 
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 In vitro, disruption of these complexes by BH3 only proteins correlates with the 
widening of the narrow tubular junction and with the fusion of the individual 
cristae. Recently we identified a new role for OPA1 in the control of stability and 
assembly of the respiratory chain supercomplexes, mitochondrial respiratory 
efficiency and respiratory growth. However, very little is known about the role of 
OPA1 and of OPA1-dependent cristae changes in vivo. 
The aim of this thesis was to explore the role of OPA1 in cell death in vivo, by 
characterizing an OPA1 overexpressing (Opa1tg) mice generated in our laboratory 
where the Opa1 transgene is targeted to a specific position in the X chromosome 
and under the control of the weak  ubiquitous human beta-actin promoter. By 
backcrossing mice in the genetic backgrounds C57/ Bl6 and SV129 we obtained 
inbred lines where OPA1 was mildly overexpressed in a variety of tissues. This 
slight increase in OPA1 levels did not alter other proteins involved in mitochondrial 
dynamics, and did not affect the development, life and fertility of the animals. We 
found that the life span of Opa1tg C57/Bl6 was not different from that of wild type 
(Wt) littermates, while it  was significantly decreased in Opa1tg SV129, mostly due 
to the development of hematologic and solid tumors. Since Opa1tg mice did not 
show any overt phenotype, we decided to analyze morphologically and histological 
every organ. Hearts were bigger in Opa1tg animals 9 months after birth. 
Histological and immunofluorescence analysis did not reveal signs of hypertrophy 
and heart functionality was indeed preserved as demonstrated by 
ecocardiographyc analysis, indicating that the retrieved cardiac hypertrophy was 
not pathological and suggesting that perhaps aging-associated heart atrophy is 
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inhibited in Opa1tg mice. To test if Opa1 overexpression interfered with the 
program of striated muscle atrophy, we turned to a well-established model of 
skeletal muscle atrophy, induced by  sciatic nerve resection. Muscle atrophy was 
significantly reduced in Opa1tg mice, where mitochondrial function was preserved 
in the denervated fibers. This result suggested that Opa1 can interfere with at 
least one form of cell damage in vivo and prompted us to verify if it could interfere 
with other well established models of necrotic and apoptotic cell death. In a model 
of isolated perfused heart ischemia reperfusion,  Opa1tg hearts were less 
susceptible to ischemic damage, and the size of the infarcted area was significantly 
reduces in  Opa1tg mice following brain ischemic damage induced by Middle 
Cerebral Occlusion (MCAo). Finally, Fas induced hepatocellular apoptosis in vivo 
was drastically reduced in Opa1tg mice where hepatic damage was accordingly 
blunted. Mechanistically, muscle and liver mitochondria from Opa1tg mice were 
resistant to cristae remodeling and cytochrome c release induced by the pro-
apoptotic BH3-only protein cBID and displayed increased efficiency of complex I 
dependent respiration, while other parameters of mitochondrial involvement in 
cell death were not affected. This increase in complex I dependent respiration 
correlated with an increase in Respiratory Chain Supercomplexes (RCS) that we 
demonstrated to be a consequence of OPA1-dependent cristae stabilization.  
Our data elucidate a role for cristae shape in different modes of cell death in 
vivo and point out a crucial role for mitochondrial ultrastructural remodeling in 
response to widespread pathological conditions, ranging from ischemia 
reperfusion to muscular atrophy. 
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 We can conclude that Opa1, cristae biogenesis and remodeling are central 
players of reversible and irreversible cell damage and death in vivo. 
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3 Mitochondria  
Mitochondria are key organelles present in every cell type, crucial for  life and 
death of the cell. The main function of mitochondria is provide energy for cellular 
processes. mitochondria are the site of oxydative phosphorylation that ensure  the 
most ATP. They are also involved in TCA cycle, fatty acid metabolism, 
hemesynthesis, and gluconeogenesis (Corrado et al., 2012). Mitochondria are 
involved in several catabolic and anabolic pathways and control Ca2+ and red-ox 
homeostasis. They are the main generators of reactive oxygen species (ROS) that 
act as second messengers. Mitochondria are implicated in main cellular pathways 
that control cell fate,  during apoptosis mitochondria release proapoptotic proteins 
that trigger the activation in the cytosol of effectors caspases, after mitochondrial 
membrane permeabilization and cristae remodeling (Rizzuto et al., 2000; 
Wasilewski and Scorrano, 2009; Apostolova et al., 2011). According to the 
endosymbiotic theory, developed in 1971 by Margulis,  mitochondria have an 
ancestral extracellular origin, deriving from primordial rickettsia-like intracellular 
bacteria that colonized the eukaryotic cell and become essential for its life 
(Margulis, 1971). Mitochondria  are  the only organelles (other than the nucleus) 
that have its own DNA, mitochondrial DNA (mtDNA) that  is independent of the 
cell's chromosomal DNA. Human mtDNA is circular double stranded DNA of about 
16,569 bp in length. Human mtDNA is maternally inherited (Sato and Sato, 2011; 
Al Rawi et al., 2011) contains 37 genes encoding 13 proteins, that are subunits of 
electron transport chain(ETC) complexes I, III, IV and V, (Attardi and Schatz, 1988) 
as well as the 22 tRNA and 2 ribosomal RNA genes required for their translation. 
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Mutations in these genes result in severe diseases, mostly because of impaired 
energy production.  According to the chemiosmotyc theory proposed by Mitchell, 
respiratory chain complexes pump protons across the inner mitochondrial 
membrane generating an electrochemical gradient, that in turn is used by ATP 
synthase to generate ATP from ADP and phosphate ions, thus coupling respiration 
to ATP production. Abnormality in this processes are termed mitochondrial 
dysfunction. This latter is associated with inherited disorders and implicated in 
common diseases such as cardiomyopaties, neurodegenerative disorders, 
metabolic syndrome, cancer, obesity and aging.  
 
3.1 Mitochondrial ultrastructure 
In the 1950s, with the developments in electron microscopy, mitochondrial 
research became focused on ultrastructural analysis. By studying electron 
micrographs Palade and Sjostrand independently revealed that mitochondria 
possess two membranes– an outer mitochondrial membrane (OMM) and a highly 
convoluted the inner  membrane (IMM), folded in a series of ridges that were 
named cristae (Palade, 1952; Sjostrand, 1953). From these pioneering works on 
structural details, at least two models of mitochondrial structure have been 
proposed: the baffle and the septa model. According to the model described by 
Palade, also known as the “baffle model”, (Fig. 1 A) cristae are invaginations of the 
IMM with broad openings to the intermembrane space (IMS), where occurs the 
ATP production through the oxidative phosphorylation. 
15 
 
 Sjostrand proposed the septa model, that differs from Palade’s model in the 
interpretation of the inner membrane structure, which consists of distinct 
compartments forming septa spanning through the matrix. Technical 
improvements of electronic microscopy allowed researchers to better inspect 
mitochondrial ultrastructure. Mitochondria are complicated organelles composed 
of compartments that carry out specialized functions. These compartments 
include OMM, IMS, IMM, cristae and matrix. The two membranes, composed of a 
phospholipid bilayer, are distinct in appearance and in physico-chemical 
properties.  
The OMM is topologically simple, varying in shape depending on whether the 
mitochondrion is shaped. Usually it is tubular in a cell when attached to the 
cytoskeleton, but sometimes it is reticulated or isolated in suspension ellipsoidal or 
spherical. The OMM is freely permeable to ions and small molecules, it has a 
composition similar to other eukaryotic membranes and contains voltage 
dependent anion channels (VDAC), responsible for metabolite flux in and out of 
mitochondria (Colombini and Mannella, 2012). The OMM is enriched by  proteins 
of the import machinery such as the mitochondrial protein translocase of the 
outer membrane (TOM) complex that functions as the gateway through which 
nuclear-encoded polypeptides can be imported into a mitochondrion (Ahting et 
al., 1999). 
The IMM is freely permeable only to oxygen, carbon dioxide, and water. Its 
structure is highly complex, including all of the complexes of the electron transport 
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system, the ATP synthase complex, and transport proteins. Almost all ions and 
molecules require special membrane transporters to enter or exit the matrix.  
Proteins are transported into the matrix via the translocase of the inner 
membrane (TIM) complex or via Oxa1 (Herrmann and Neupert, 2000). 
Mitochondrial  tubular cristae represent specific compartments connected to the 
IMM by narrow tubular junction, called cristae junctions  (Perkins et al., 1997; 
Mannella et al., 1997). Electron tomography revealed that the diameter of cristae 
junctions is about 28 nm and the average distance across the OMM and IMM is 20 
nm (Fig. 1 B). Cristae compartment represents the site of oxidative 
phosphorylation where the respiratory chain is located, and cytochrome c is 
separated from the IMS by narrow cristae junctions. The ratio of cristae/ 
mitochondrion surface area can be viewed as the ATP synthesizing capacity of the 
mitochondrion (Gilkerson et al., 2003; Vogel et al., 2006; Perotti et al., 1983). The 
cristae shape is dynamic: upon activation of mitochondrial respiration, ‘‘orthodox’’ 
mitochondria become ‘‘condensed,’’ with an expanded cristae space (Hackenbrock 
et al., 1980). As we will see below, the changes in cristae shape are important 
determinants of apoptosis and mitochondrial respiratory efficiency. 
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Figure 1 – Mitochondrial ultrastructure. (A) A text book-like representation of the baffle 
model adapted from (B) Three-dimensional reconstructions of isolated rat liver 
mitochondria obtained by highvoltage electron tomography. OM: outer membrane, IM: 
inner membrane, C: selected cristae; arrowheads point to narrow tubular regions that 
connect cristae to periphery and to each other. Bar, 0.4 μm. Adapted from (Frey and 
Mannella, 2000).  
 
3.1.1 Mitochondria respiratory chain complexes (OXPHOS) 
Mitochondria  are central players in energy metabolism. They provide most of the 
ATP by oxidative phosphorylation (OXPHOS). In the tricarboxylic acid cycle (TCA) 
the acetyl-CoA produced by catabolic pathways such as glycolysis and fatty acid 
oxidation, is oxidized and the energy, released in form of reduced form of 
nicotinamide–adeninedinucleotide (NADH) and reduced form of flavin–adenine 
dinucleotide (FADH2), fuels  the electron transport chain (ETC) (Fig. 2). The 
components of ETC are located in the IMM and include four complexes (CI, CII, CIII 
and IV)  and mobile carriers coenzyme Q (CQ) and cytochrome c. While the 
electrons pass along the ETC the energy released is used to expel protons from 
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matrix to the IMS and to build up the proton motive force. Only three of the four 
complexes act as proton pumps; Complex II is not able to pump protons. The 
proton motive is then utilized by ATPase to generate ATP from ADP and phosphate 
Pi, allowing the protons to re-enter the mitochondrial matrix, thus coupling 
electron transport and proton pump to ATP synthesis.  
The coupling of electron transport to ATP synthesis is the main postulate of the 
chemiosmotic theory, for which in 1978 Peter Mitchell was awarded by a Nobel 
Prize in chemistry.  
 
Figure 2- Mitochondrial respiratory chain. For mammals, the respiratory chain consists of 
four enzyme complexes (complexes I - IV) and two intermediary substrates (coenzyme Q 
and cytochrome c). The NADH+H+ and FADH2 produced by the intermediate metabolism 
are oxidized further by the mitochondrial respiratory chain to establish an electrochemical 
gradient of protons, which is finally used by the F1F0-ATP synthase (complex V) to 
produce ATP, the only form of energy used by the cell. In this simple representation of the 
respiratory chain, the supramolecular organization (supercomplexes, dimers) is not 
shown. (From:Bellance Nadege et al., Mitochondria: from bioenergetics to the metabolic 
regulation of carcinogenesis Frontiers in Bioscience 14, 4015-4034, January 1, 2009) 
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3.1.2 OXPHOS components 
 
Complex I  
Complex I or NADH dehydrogenase is the largest enzyme of the respiratory chain 
(almost 1MDa in size) and the entry point of the ETC. It couples electron transport 
from NADH to ubiquinone via flavin mononucleotide (FMN). Complex I consists of 
45 subunits, encoded by both mtDNA and nuclear DNA, whose mutations lead to 
the most common mitochondrial diseases. The enzyme is the main site of ROS 
production which can lead to mtDNA damages and is involved in Parkinson’s 
disease and aging. The enzyme has an “L” shape structure, as shown by a very 
recent crystal structure of the entire, intact complex I (from T. thermophilus) at 
3.3 Å resolution (Baradaran et al., 2013) 
 
Complex II 
Complex II or succinate deydrogenase  (SDH) is the second entry point of electrons 
to the ETC. It directly extracts electrons from succinate, an intermediate of the TCA 
cycle, using flavin adenine dinucleotide (FAD) as coenzyme, three iron–sulfur 
clusters and cytochrome b5. Complex II consists of four nuclear encoded proteins. 
Mutations in complex II are extremely rare. The 70 kDa flavoprotein (SDHA) and 
complex II assembly factor (SDHAF1) are responsible for mitochondrial respiratory 
chain diseases. Mutations in the other three subunits (SDHB, SDHC, SDHD) and the 
second assembly factor (SDHAF2) have so far only been associated with hereditary 
paragangliomas and phaeochromocytomas  (Jackson et al., 2013). 
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Complex III 
Complex III or cytochome c oxidoreductase, catalyzes electron transfer from 
reduced CoQ to cytochrome c and pumps two protons from matrix to the IMS. 
Complex III is composed by 10 subunits encoded by nuclear DNA and 1 by mtDNA. 
Mutations in complex III subunit genes are involved in debilitating and often fatal 
disorders (Tucker et al., 2013). 
 
Complex IV 
Complex IV or cytochrome c oxidase (COX) is the terminal enzyme of the 
respiratory chain. It transports electrons from cytochrome c and delivers them to 
oxygen to generate two water molecules.  In this reaction four protons are 
pumped to the IMS. This complex consists of 14 subunits, three codified by 
mtDNA, that form the catalytic core of the enzyme, and 11 by nuclear DNA (Balsa 
et al., 2012). Genetic mutations affecting COX result in severe, often fatal, 
metabolic disorders. Such disorders usually manifest in early childhood and affect 
tissues with high energy demand. Only few COX genetic disorders are caused by 
mutation in mtDNA. The majority of COX defects are associated with pathogenic 
mutations in the nuclear encoded subunits. These mutations are located in genes 
encoding COX-specific assembly proteins including SURF1, SCO1, SCO2, COX10, 
and COX15. Dysfunctional COX assembly results in the most severe mitochondrial 
diseases (Pecina et al., 2004). COX15 was identified in yeasts as one of COX 
assembly factors. It plays a key role in the mitochondrial heme biosynthetic 
pathway in which protoheme (heme B) is converted to heme A, the prosthetic 
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heme group in COX. COX deficiency results in an early onset, fatal hypertrophic 
cardiomyopathy, severe loss of myofibrillar material and greatly increased 
numbers of mitochondria with abnormal shapes, abnormally arranged cristae, and 
numerous matrix densities (Antonicka et al., 2003) Mice with a general deletion of 
COX15 are embryonic lethal. A muscle specific COX15 knock-out (KO) mice display 
a COX defective mitochondrial myopathy (Viscomi et al., 2011). 
 
ATP synthase 
ATP synthase or Complex V is a large protein complex located in the IMM that uses 
the proton motive force to convert ADP and Pi in ATP. Complex V is composed of 
two functional domains F0 located in the IMM and F1 in the matrix. F0 acts as a 
pore transferring protons to the F1 by a rotatory  movement. Complex V consists 
of 16 subunits encoded by both mtDNA and nuclear DNA. Complex V deficiency 
associates mostly with an early onset in the neonatal period with severe multi 
organ failures, and high mortality  (Li XY et al., 2013). 
 
3.1.3 Respiratory Chain Supercomplexes (RCS) 
 
Mitochondrial respiratory chain is organized in supramolecular units called 
supercomplexes. The first “fluid model” in which mitochondrial respiratory chain 
complexes were free-moving entities linked by the mobile carriers coenzyme Q 
and cytochrome c, has been proposed  by Hackenbrock  (Hackenbrock et al., 
1986).  
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A second “solid model” proposes that a supercomplex formed by complexes I, III 
and IV is the only functional mitochondrial electron transport chain (Schagger and 
Pfeiffer, 2000). The first proposed fluid model was challenged by the finding that 
all respiratory chain complexes, except for complex II, can associate into 
supercomplexes (Lapuente-Brun et al., 2013).  
The best experimental system to investigate RCS is the blue-native polyacrylamide 
gel electrophoresis (BNGE) introduced by Schagger in 1995, which allows the 
separation of protein complexes preserving their physiological structure and 
activity. Using BNGE, Shagger found a variety of  RCS of which perhaps the most 
prominent one is the I+III+IV also called the “respirasome” supercomplex, as well 
as the other supercomplexes I+III  and III+IV (Acin-Perez et al., 2008).  Studies in 
cells derived from patients with OXPHOS deficiencies revealed which are the 
complexes important for the structure of the supercomplexes. Low levels of 
supercomplexes are detected in the absence of complex III (Acin-Perez et al., 2004) 
and complex IV (Diaz et al., 2006). These two complexes have been found to be 
required for the stability of complex I. On the other hand the lack of  complex I 
prevents supercomplexes formation, but has not been found to affect complex III 
or IV stability. Functionally,  the electrons generated from NADH substrates feed  
complex I promoting respiration from complex I to complex III and complex IV; 
while electrons generated from FAD-linked substrates feed complex II until 
complex III and complex IV. The electron flow from complex II to complex III is 
independent from the flow that takes place in I to III. 
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 These two pathways use separate CoQ pools to supply electrons from complex I 
and complex II to complex III. The two CoQ pools compete for the delivery of 
electrons to complex III. Complex IV receives electrons from either one or the 
other pathway depending on the supercomplexes. In particular, Cox7a2I that has 
been renamed supercomplex assembly factor I (SCAFI) has been identified to be 
required to stabilize the  interaction between complexes III and IV and therefore to 
favor oxidation of NADH linked substrates. Interestingly, C57/BL6 mice lack SCAFI, 
having a profound impact on their mitochondrial metabolism and the fuel choice.   
3.2 Mitochondria and cell death 
 
Cell death is a key physiological process both in the development and in the 
homeostasis of multicellular organisms. Mitochondria are essential organelles for 
cell survival, but they also are recognized as central players in cell death. Cell death 
may be programmed or non-programmed.  According to its morphological 
appearance cell death can be classified in apoptotic, autophagic or necrotic, and 
mitochondria can actively contribute to all of these cell deaths (Kroemer et al., 
2009).  
 
3.2.1 Apoptosis  
Apoptosis is a physiological process that occurs in multicellular organisms, also 
known as  programmed cell death (PCD) (Lockshin and Williams, 1965). The term 
apoptosis was first coined by Currie and co-workers and it is used to describe the 
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“dropping off” or “falling off” of petals from flowers or leaves from trees, a 
necessary part of the life cycle (Kerr et al., 1972).  
In multicellular organisms, apoptosis contributes to homeostasis through the 
elimination of surplus or damaged cells. During embryonic development, it is 
essential for successful organogenesis and crafting of complex multicellular 
tissues, as elimination of the webbing between digits in humans and mice or the 
mammary tissue in males. During adulthood, apoptosis guarantees the 
maintenance of normal cellular homeostasis and immunity regulation.  
Impairment of apoptosis contributes to the development of several pathological 
conditions: insufficient apoptosis manifests as cancer or autoimmunity, while 
accelerated cell death is evident in acute and chronic degenerative diseases (Kerr 
et al., 1972; Kroemer and Zitvogel, 2007; Meier et al., 2000). Like other forms of 
cell death, apoptosis can be recognized by a series of morphological and 
biochemical characteristics. Apoptosis is characterized by loss of cell-cell contact, 
cellular shrinkage, pyknosis, chromatin condensation, nuclear fragmentation, 
membrane blebbing, appearance of apoptotic bodies and rapid phagocytosis by 
neighbouring cells (Kerr et al., 1972).  
There are two main apoptotic pathways in mammalian cells, depending on the cell 
type and on the death stimulus. The extrinsic pathway is triggered by the 
activation of “death receptors” that after the formation of the protein complex 
called “death inducing signaling complex” (DISC) leads to the activation of caspase 
8 followed by the activation of the effector caspase 3. The intrinsic apoptotic 
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pathway is triggered by intracellular apoptotic signals and is mediated by 
mitochondria (Scaffidi et al., 1998; Scaffidi et al., 1999).  
The extrinsic apoptotic pathway is initiated at the cell surface via activation of 
specific death receptors. After the activation of both pathways, mitochondria 
release in the cytosol cytochrome c that form a complex with Apaf-1 to activate 
caspase 9 which in turn activates the effector caspase 3. The mitochondrial 
pathway of apoptosis is tightly regulated by the central regulators of cell death 
BCL-2- proteins, that act  upstream of mitochondria and include both anti and pro-
apoptotic members (Fig. 3).  
 BCL-2 family members posses conserved α-helices with sequence conservation 
clustered in the so called BCL-2 homology (BH) domains.  According to their 
functions and to the homology displayed in the BH domains, BCL-2 family proteins 
can be subdivided in three principal groups. The anti-apoptotic or  prosurvival BCL 
-2 proteins, such as BCL -2 itself, BCL -xL, BCL -w, BCL -1 and A1 that display a 
sequence conservation in all four domains (BH1-4). They inhibit cell death through 
direct interactions with the pro-apoptotic members. The pro-apoptotic molecules 
display less sequence conservation of the first alpha-helical segment BH4. BH3 is of 
particular importance for the pro-apoptotic family members that can be further 
subdivided into ‘‘multidomain’’ and ‘‘BH3-only’’ proteins. Multidomain pro-
apoptotic members such as BAX and BAK display sequence conservation in BH1-3 
domains and are believed to participate directly in OMM permeabilization. The 
BH3-only members like Bim, Bid, Bad, Bik, Noxa, Puma, Hrk, Bmf, display sequence 
conservation only in the amphipathic α-helical BH3 domain and are important to 
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sense different stress in the cell and to initiate apoptosis (Scorrano and Korsmeyer, 
2003). The BH3-only proteins are further classified as sensitizer, for example Noxa, 
Bfm or Bik exert their  pro-apoptotic role by interacting with the pro survival 
members and antagonizing their function, and as activators, like Bid and Bim, 
Puma that have the ability to directly activate Bax and Bak (Cheng et al., 2001) 
(Ren et al., 2010). 
 
 
 
Figure 3- Summary of anti- and proapoptotic BCL-2 family members. BCL-2 homology 
domains are highlighted. From  (L. Scorrano, S.J. Korsmeyer / Biochemical and Biophysical 
Research Communications 304 (2003) 437–444 ) 
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3.2.2 Mitochondria in apoptosis 
 
Mitochondria are key organelles in the modulation of apoptosis, since they release 
both pro- and anti-apoptotic factors. 
 When pro-apoptotic signal predominates, OMM loses its integrity resulting in loss 
mitochondrial membrane potential, decrease ATP synthesis and release of 
apoptotic regulators from IMS to the cytosol. Among them cytochrome c, 
SMAC/DIABLO, OMI/HTRA2 , apoptosis–inducing factor (AIF) and endonuclease G. 
Once released into the cytosol, these mitochondrial proteins activate both 
caspase-dependent and independent cell death pathways  (Saelens et al., 2004). 
SMAC/DIABLO and OMI/HTRA2 contribute to the apoptotic cascade by inactivation 
of proteins that inhibit effector caspases (Du et al., 2000; Verhagen et al., 2000). 
AIF (Susin et al., 1999) and endonuclease G  (Li et al., 2001) have been proposed to 
mediate nuclear DNA damages in a caspase-independent way. Cytochrome c is a 
crucial factor for caspase activation upon an apoptotic stimulus (Liu et al., 1996).  
The OMM was shown to be impermeable to cytochrome c (Wojtczak et al., 1972), 
but in most apoptotic conditions it becomes permeable, resulting in release of 
cytochrome c into the cytosol. The release of cytochrome c into the cytosol 
requires a crucial process, mitochondrial outer membrane permeabilization 
(MOMP), that is mainly controlled by BCL-2 family members (Bender and 
Martinou, 2013; Bender and Martinou, 2013). After an apoptotic stimulus BH3-
only proteins become activated and translocate to the OMM, where they activate 
multi domain pro-apoptotic. Activation of BAX/BAK by their oligomerization is 
required for the permeabilization of the OMM (Wei et al., 2000). 
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 Once released into the cytosol, cytochrome c forms a caspase-activating complex 
with Apaf-1 called “apoptosome”, which activates caspase 9 to result in the 
activation of effector caspases 3 and 7 (Zou et al., 1997). 
 
3.2.3 Fas- hepatocellular apoptosis and mitochondria 
 
Apoptosis is a distinct feature of many liver diseases, since it can occur in response 
to viral infections and exposure to hepatocarcinogen agents, excessive alcohol 
consumption or genetic mutations. Liver resident cells, in particular hepatocytes, 
cholangiocytes, activated stellate cells and  Kupffer cells, are susceptible to death 
receptor mediated apoptosis, due to the ubiquitous expression of these receptors 
in the organ (Chakraborty et al., 2012; Guicciardi et al., 2013). In the healthy liver, 
apoptosis is not a frequent mode of hepatic cell demise, but when it occurs 
morphological and biochemical characteristics do not differ from that observed in 
other cells (Feldmann, 2006). Liver death receptors belong to the tumor necrosis 
factor receptor (TNFR) superfamily, that includes TNFR1, Fas (CD95, Apo-1), the 
TNF-related apoptosis-inducing ligand (TRAIL), receptor activator of NF-kB ligand 
(RANKL), CD40 ligand (CD40L) another members of TNF family of cytokines. The 
members of this family are type-I transmembrane proteins with a C-terminal 
intracellular tail, a membrane-spanning region, and an extracellular ligand-binding 
N-terminal domain. Death receptors are characterized by a cytoplasmic sequence 
known as the death domain (DD), that enables the receptor to trigger cytotoxic 
signals when bind by their respective ligands. The DD domain is crucial for the 
induction of apoptosis. 
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 Ligands that activate death receptor are cytokines that belongs to the TNF protein 
family.  These proteins are also known as death ligands and they are mainly 
expressed as type-II transmembrane proteins containing an intracellular N-
terminal domain, a transmembrane region, and a C-terminal extracellular tail 
(Guicciardi and Gores, 2009). The most studied death receptors are Fas, TNF-α and 
TRAIL and they are abundantly expressed in the liver and their activation is 
associated with hepatocyte apoptosis in a wide variety of liver diseases (Faubion 
and Gores, 1999). The Fas antigen, coded by the structural gene for mouse 
lymphoproliferation mutation (lpr), is a cell surface protein belonging to the 
TNF/nerve growth factor (NGF) receptor family, and mediates apoptosis. The Fas 
antigen messenger RNA is expressed in the thymus, liver, heart, lung and ovary. In 
particular Fas is constitutively expressed by every cell type in the liver. Ligation of 
death receptor Fas by its natural  ligand, FasL, or by agonistic antibodies has 
dramatic consequences in vivo, resulting in lethal fulminate  apoptotic liver 
destruction (Adachi et al., 1995; Ogasawara et al., 1993). Upon ligation by its 
cognate ligand FasL, the adaptor molecule Fas-associated death domain (FADD) is 
recruited to the receptor leading to the formation of the death inducing signaling 
complex (DISC) responsible for the activation of the initiator caspase 8 (Kischkel et 
al., 1995). Activation of caspase 8 at the DISC can trigger the apoptotic signaling 
cascade. Two signaling pathways of Fas-mediated apoptosis has been established, 
depending on the amount of DISC formation and active caspase 8. Based on this 
cells expressing Fas are classified in two types (Scaffidi et al., 1998). 
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 In type I cells high levels of CD95 DISC formation and high amounts of active 
caspase 8 directly leads to the activation of downstream effector caspases 3 and 7. 
 In type II cell, levels of DISC are lower and only a small amount of active caspase 8 
is produced. This cell type requires contribution of mitochondrial involvement to 
the amplification of caspase cascade. Caspase 8 in type II cells cleaves and 
activates pro-apoptotic BCL-2 family member BID, which translocates to 
mitochondria where it activates proapoptotic effectors of BCL-2 family, BAX and 
BAK and finely results in cytochrome c release (Lavrik et al., 2005). 
More recently Jost have shown that levels of X-linked inhibitor of apoptosis 
protein (XIAP) determine whether a cell will undergo type I or type II Fas-mediated 
apoptosis (Fig. 4). Accordingly, in type II cells, sufficient amounts of XIAP can bind 
and block the activation of executioner caspases. Apoptosis in these cells occurs 
after OMM permeabilization by BAX and BAK, that allows release of proteins such 
as Smac, Omi that antagonize XIAP (Jost et al., 2009; Parsons and Green, 2011) 
Hepatocytes have been classified as type II cells based on observations that Fas-
induced hepatocellular apoptosis is critically dependent on mitochondrial 
activation. Mice lacking BID, BAX/BAK double knockout mice, BCL-2 transgenic 
mice were protected from hepatocellular apoptosis following injection with 
agonistic anti Fas antibody, indicating that mitochondrial amplification loop is 
essential for the apoptosis in hepatocytes (Lacronique et al., 1996; Rodriguez et al., 
1996; Yin et al., 1999; Wei et al., 2001). 
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Fig. 4. Type I versus Type II death receptor signaling. Ligation of CD95 induces the 
recruitment of an adaptor protein FADD via homotypic death domain (DD). FADD then 
recruits caspase-8 via death effector  domain (DED) interactions. Depending on the levels 
of the executioner-inhibitor protein XIAP, apoptosis will then proceed via one of two 
ways. In Type I cells, XIAP levels are low, and caspase-8–mediated cleavage and activation 
of the executioner caspases, caspase-3 and caspase-7, is sufficient to drive apoptosis. In 
Type II cells, XIAP is present in sufficient amounts to bind to and block the activation of the 
executioner caspases, preventing apoptosis. Thus, in Type II cells, caspase-8–mediated 
cleavage of BID, subsequent activation of BAX and BAK, and release of the XIAP inhibitors 
Smac and Omi from mitochondria during mitochondrial outer membrane permeabilization 
(MOMP) are required for efficient executioner caspase activation and apoptosis to 
proceed. From ( Jost et al., 2009)  
 
3.2.4 Mitochondria in Skeletal Muscle Atrophy  
 
Muscle is the major consumer of fuels and ATP in the body. Based on functional 
and structural characteristics, muscle tissue can be divided into three groups: 
skeletal, cardiac and smooth. Cardiac and skeletal muscles are striated muscles, 
tissues with high energy demand.  Skeletal muscle is a major site of metabolic 
activity and the largest organ system in all mammals, the most abundant tissue in 
the human body, accounting for almost 40% of the total body mass (Romanello 
and Sandri, 2010).  
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Skeletal muscle is a plastic tissue that responds and adapts its mass in response to 
physical activity, metabolism and hormones, by affecting pathways that regulate 
protein and cellular turnover.  Skeletal and cardiac muscles are also tissues with 
limited proliferative capacity. Thus, their cell size is determined by the balance 
between synthesis of new proteins and the degradation of existing ones, both 
process with a high ATP demand. Muscle energy level is one of the cellular 
checkpoints that decide either to promote growth and hypertrophy or activate 
protein breakdown and atrophy (Sandri, 2008). Adult muscle growth occurs mainly 
by protein synthesis and decreases in protein degradation, while muscle atrophy 
occurs when protein degradation rates exceed protein synthesis resulting in gross 
reduction in fiber size, and may be induced in adult skeletal muscle in a variety of 
conditions, including starvation, denervation, cancer cachexia, heart failure and 
aging (Schiaffino et al., 2013).  
Muscle protein degradation occurs mainly through two ATP-dependent proteolytic 
systems. Calpain, caspase-3, ubiquitin-proteasome, and autophagy are the 
proteolytic systems involved in protein breakdown during disuse muscle atrophy 
(Powers et al., 2007; Sandri, 2008). Functionally, skeletal muscle is a complex 
tissue composed of  two major types of fibers: slow-twitch oxidative (type I) fibers 
designed for low-intensity long-lasting contractions, and fast-twitch glycolytic 
(type II) fibers designed for high-intensity short-duration contractions.  The main 
factor that varies substantially across fiber types is mitochondrial density, slow 
twitch type I fibers typically displaying a two- to three-fold higher mitochondrial 
density and substantially lower non oxidative ATP synthesis capacity compared to 
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fast twitch type II fiber (Picard et al., 2012). The different fiber types display also 
diverse susceptibility to atrophy. Oxidative fibers are more resistant, while 
glycolytic fibers are more prone to loose proteins and organelles(Sandri, 2008). 
Skeletal and cardiac muscle possess two distinct populations of mitochondria that 
differ not only in their cellular location, but also in certain biochemical properties. 
Subsarcolemal mitochondria (SS) are located beneath the sarcolemma, and 
interfibrilar mitochondria (IMF) are situated between the myofibrils (Palmer et al., 
1985). These two mitochondrial populations are characterized by differences in 
the cristae morphology. Lamelliform cristae are predominant in the SS, while 
tubular cristae are mostly present in IMF (Riva et al., 2006). IMF mitochondria are 
more abundant, representing about 80% of total mitochondria in muscle fibers 
(Hoppeler, 1986).  
In addition to their structural and biochemical characteristics, the two populations 
of mitochondria display different bioenergetic capacities and possess distinct 
antioxidant defenses (Servais et al., 2003). For example IMF display higher 
OXPHOS activity compared to SS mitochondria (Padrao et al., 2011). Other studies 
revealed  that during atrophy induced by denervation SS mitochondria are less 
susceptible to apoptotic stimuli  and  produce higher level of ROS with respect to 
IMF (Adhihetty et al., 2007). Playing a central role in energy production and in the 
regulation of cell life and death, alterations in mitochondrial function are primarily 
involved in myocyte atrophy during aging and disuse muscle wasting (Calvani et 
al., 2013).  
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Disuse muscle atrophy has been associated with loss of mitochondria, changes in 
mitochondrial morphology, increased ROS production, and impaired mitochondrial 
function.  Regarding mitochondrial loss, it involves mitochondrial elimination and 
changes in mitochondrial biogenesis. Biogenesis is regulated by a family of 
transcriptional co-activators: the peroxisome proliferator-activated receptor 
gamma (PGC), including peroxisome proliferator-activated receptor-γ coactivator-
1α and β (PGC-1a and PGC-1b). In particular PGC-1α interact and activates several  
transcription factors including PPARs, nuclear respiratory factors (NRFs), myocyte 
enhancing factors (MEFs), estrogen-related receptor (ERR), forkhead box (FOX)O1 
and yin-yang (YY) (Olesen et al., 2010). PGC-1α can induce mitochondrial 
biogenesis and respiration by connecting the nuclear regulatory events with 
mitochondrial transcriptional machinery. PGC-1α binds and activates 
(NRF2/GABPA) and co-activates NRF1, PPARs and ERRs, increasing their 
transcriptional activity (Baldelli et al., 2013) NFRs activate the mitochondrial 
transcription factor A (TFAM)  which  binds mtDNA and regulates both 
mitochondrial transcription initiation and mtDNA copy number (Campbell et al., 
2012). 
 Thus PGC-1α can be considered a master regulator of mitochondrial biogenesis 
widely expressed in tissues with high energy demand like brown adipose tissue, 
brain, heart and kidney as well as in skeletal muscle (Tritos et al., 2003). In skeletal 
muscle PGC-1α is primarily involved in the regulation of multiple pathways. 
Increased levels of PGC-1α through transgenic expression reduce muscle atrophy 
during denervation or fasting.  
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Therefore the levels of PGC-1α dramatically decrease after denervation and other 
types of muscle wasting (Sandri et al., 2006). PGC-1α levels decrease with aging 
and a slightly increased expression of PGC-1α  during aging preserves 
mitochondrial function and prevent muscle wasting, by reducing apoptosis, 
autophagy and proteasome degradation (Wenz, 2009). 
 
3.2.5 Mitochondria in Ischemia and Reperfusion Injury 
 
Mitochondria play a central role in ischemic damage. Mitochondrial dysfunction is 
considered to be one of the main mechanisms involved in ischemic injury in heart, 
brain, liver, kidney, and other organs and tissues (Borutaite et al., 2013). 
Mitochondria functionality is affected during ischemia as a consequence of oxygen 
deprivation that further influence cell viability, through a wide set of events. Loss 
of mitochondrial function results in reduced ATP synthesis and increase in ATP 
hydrolysis, impairment in ionic homeostasis, formation of reactive oxygen species 
(ROS) and release of proapoptotic proteins. This biochemical dysfunctions are 
recognized as key factors in the generation of irreversible damage (Di Lisa and 
Bernardi, 2006; Duchen, 2000; Lesnefsky et al., 2001; Crow et al., 2004). The 
accumulation of lactic acid during ischemia results in a drop of  pH that inhibits 
ATP production from glycolysis. pH normalization results in increased intracellular 
sodium ions that compete with calcium for  extrusion; this in turn leads to an 
increase in the intracellular calcium.  
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Mitochondria act as buffering system, removing intracellular calcium that 
ultimately results in mitochondrial calcium overload. Reintroduction of the blood 
flow during the reperfusion is of primary importance to recovery the tissue, 
however the reperfusion phase is also the period where most of the cells die. 
During reperfusion calcium entry in mitochondria through the mitochondrial 
calcium uniporter (MCU) (De Stefani et al., 2011; Chen et al., 2003b). 
Mitochondrial calcium overload is a major feature of cell injury (Crompton, 1999; 
Carreira et al., 2011). Reperfusion can potentially kill the cell trough increase in 
reactive oxygen species (ROS) generation. Mitochondria are the key players in ROS 
production. The major sources of ROS are represented by uncoupling of the 
electron transport chain (ETC) complexes I and III, monoamine oxidase (MAO) and 
p66Shc activity  (Tompkins et al., 2006; Chen et al., 2003b; Di et al., 2009). In cells  
acutely exposed to hypoxia mitochondria respond with increased ROS  production. 
The ROS released during hypoxia leads to the stabilization of the transcription 
factor hypoxia-inducible factor (HIF), the principal regulator of transcriptional 
responses to hypoxia. HIF members have  the ability to regulate several number of 
genes (Guzy and Schumacker, 2006). For example in response to hypoxia,  HIF-1 
strongly upregulates  Bnip3 expression (Bcl-2 and adenovirus E1B 19 kDa-
interacting protein 3), which induces oxidative stress (Guzy and Schumacker, 2006; 
Kubli et al., 2008). Activation of Bnip3 by its homodimerization promotes 
mitochondrial swelling and cytochrome c release, via disruption of Opa1 oligomers 
and release of Opa1 in the cytosol, interfering with fusion fission processes, 
important for normal function of mitochondria (Lee et al., 2009). 
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 Alteration in mitochondrial dynamics have been implicated in I/R injury. Ischemia 
induces a Drp1 dependent fission, moreover pharmacological inhibition of 
mitochondrial fission decreases opening of mitochondrial permeability pore and 
reduces  infarct size in a mouse model of myocardial I/R injury(Ong and 
Gustafsson, 2012). Other studies showed that Mfn-2 knockout hearts were able to 
develop higher pressures during post-ischemic reperfusion and exhibited 
diminished cell death following in vivo regional ischemia and reperfusion injury, 
indicating that  Mfn-2 not only serves to maintain mitochondrial morphology in 
cardiac myocytes but also promotes MPTP opening in the heart under conditions 
of stress (Papanicolaou et al., 2011). Ischemia induces loss of Opa1 in H9c2 cell line 
and overexpression of Opa1 keep mitochondrial morphology during ischemia. 
Coronary ligation in adult rat results in reduced Opa1 levels with increased 
mitochondrial fragmentation (Chen et al., 2009). Altered mitochondrial dynamics 
toward fission correlate with increased ROS production, impaired function and 
activation of cell death (Shenouda et al., 2011; Frank et al., 2001; Germain et al., 
2005; Gomes et al., 2011; Yu et al., 2006). Exacerbated ROS production and 
calcium overload trigger mitochondrial membrane permeability that ultimately 
leads to the opening of the mitochondrial permeability transition pore (MPTP). A 
voltage-dependent, high-conductance channel located in IMM. MPTP  makes IMM 
permeable to solutes with molecular masses up to about 1.5 kDa, thereby causing 
collapse of the membrane potential and ATP depletion (Di Lisa and Bernardi, 2006; 
Zoratti and Szabo, 1995; Bernardi et al., 1999).  
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Damaged mitochondria can release cytochrome c and activate effector caspases 
culminating with apoptosis. Although the precise mechanisms by which 
cytochrome c is released from mitochondria during ischemia are not fully 
understood, at least three pathways have been discussed in the literature (Fig. 5) 
(Borutaite et al., 2013). First matrix swelling  and rupture of OMM caused by MPTP 
lades to the release of the proteins from IMS, one of that is cytochrome c which 
after binding with Apaf-1 in the cytosol activates caspase 9 triggering apoptotic 
cascade (Di Lisa and Bernardi, 2006). Another pathway  of cytochrome c release 
from mitochondria involves  activation  of  the proapoptotic  BH3 only members of 
BCL-2 family. The BCl-2 proteins have been found to play an important role in I/R. 
Transgenic mice overexpressing BCL-2 in the heart are more resistant to apoptosis 
and I/R, moreover they show smaller infarct size and improved postischemic  
function compared with wild type littermates Similarly Bax ablation in the heart 
improves myocardial tolerance to I/R injury, showing reduced infarct 
size(Hochhauser et al., 2003). Finely cytochrome c release during ischemia may be 
related to changes in the phospholipid composition of the OMM, in particular 
cardiolipin. Oxidative damage to cardiolipin lead to the alteration of the 
mitochondrial membrane fluidity, ion permeability structure and function of 
components of the mitochondrial electron transport chain, resulting in reduced 
mitochondrial oxidative phosphorylation efficiency and apoptosis (Ong et al., 
2010). Cytochrome c release during ischaemia, caused by OMM permeabilization, 
is a major determinant of ROS production by mitochondria under 
pathophysiological conditions (Pasdois et al., 2011). 
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 Cell death during  ischemia and reperfusion injury is characterized by typical 
features of apoptosis, necrosis and autophagy.   During ischemia, most cells die via 
necrosis due to extended oxygen deprivation and ATP depletion. Upon 
reperfusion, both apoptosis and necrosis are activated, the acute loss of cells 
during reperfusion is primarily due to necrosis (Ong and Gustafsson, 2012). A key 
regulator of both necrotic and apoptotic cell death is MPTP. MPTP opening allows 
water and solutes to enter mitochondria that will result in increased matrix 
volume with subsequent rupture of the OMM. The latter facilitates release of 
cytochrome c which in turn promotes apoptotic cell death.  Moreover MPTP 
induction contributes to the loss of electrochemical gradient which in turn causes 
ATP synthase to work in reverse, consuming ATP. This process may be preceded by 
a transient but massive ROS production and calcium overload and culminate in 
necrotic cell death (Carreira et al., 2011). Finally, autophagy is  another form of cell 
death that has been shown to play a role in I/R injury. Autophagic cell death was 
commonly observed in the heart with acute and chronic ischemia, heart failure, 
and aging (Hein et al., 2003). In conclusion, ischemia reperfusion injury appears to 
be a mixture of apoptotic, necrotic and autophagic cell death in which 
mitochondria are important mediators and regulators (Murphy and Steenbergen, 
2008).  
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Figure 5 - Mechanisms and consequences of ischaemia-induced cytochrome c release 
from mitochondria. During ischaemia, mitochondrial cytochrome c may be released into 
the cytosol by mechanisms involving Bcl-2 proteins, lipids, or MPTP opening. In the 
cytosol, cytochrome c can participate in the activation of caspases, leading to apoptosis. 
Loss of cytochrome c from mitochondria may result in increased production of ROS, 
which, in turn, may lead to further oxidative damage to mitochondria. Loss of cytochrome 
c from mitochondria may result in mitochondrial dysfunction and ATP depletion, causing 
necrosis. From Barutaite et al., 2013 
 
 
3.3 Mitochondrial shape and dynamics 
 
Mitochondria are highly dynamic and heterogeneous organelles. Their 
morphology, size and distribution are actively controlled to respond to the 
functional needs of the cell.  Studies from electron microscopy have shown that 
mitochondrial content and morphology can be highly variable across tissues and 
exhibit distinct patterns of fuel use and biosynthetic capacities (Vafai and Mootha, 
2012). Morphology of mitochondria differs among different cell types.  
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In fibroblasts mitochondria are usually long filaments, whereas in hepatocytes are 
more spheres or ovoids, and can be solitary. In epithelial cells, mitochondria are 
tubular and they form an intricate network, while in native vascular smooth 
muscle mitochondria are ovoid or rod-shaped organelles. Mitochondria can vary 
even within individual cells. In skeletal muscle two populations of mitochondria 
can be retrieved: they are mostly globular in the perinuclear region, while 
subsarcolemal mitochondria are rod shaped and smaller than the ones embedded 
among myofibrilis. In pancreatic acinar cells there are three different regional 
groups of functionally unconnected mitochondria; one group in the peripheral 
basolateral region close to the plasma membrane, another around the nucleus and 
a third positioned in the periphery of the granular region separating the granules 
from the basolateral area (McCarron et al., 2013; Scorrano, 2013). 
Mitochondrial shape ranges from spherical, grain-like, individual entities to long, 
branched filaments that, ultimately, might form interconnected tubules, 
depending on environmental conditions, cell type, and organism. (Fig. 6 A, B) 
(Dimmer and Scorrano, 2006). Mitochondrial morphology appears to be 
determinant of  mitochondrial function,(Youle and van der Bliek, 2012; Shutt et al., 
2012) which is precisely reflected by mitochondrial dynamics (Sjostrand, 1953). 
Mitochondrial dynamics refers to the fusion and fission cycles that constantly 
remodel mitochondrial network (Fig. 6 C,D).  
Fission cuts a tubule into two while fusion can link two tubules together to form a 
longer tubule or a branch. In addition to complete fusion, a transient form of 
fusion was recently identified in which two mitochondria come into close 
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apposition, exchange soluble IMS and matrix proteins, and separate, maintaining 
the original morphology. Transient fusion, called “kiss-and-run”, supports 
mitochondrial motility and metabolism (Youle and van der Bliek, 2012).  
Finally, mitochondria move along cytoskeletal tracks to sites of high-energy 
demand, and change their  shapes change continually through the combined 
actions of fission, fusion and motility in response to the cellular environment and 
differentiation (Chang et al., 2006; Hollenbeck and Saxton, 2005; Saxton and 
Hollenbeck, 2012). Mitochondrial morphology and ultrastructure are determined 
by mitochondria-shaping proteins that include both pro-fusion an pro-fission 
members (Griparic and van der Bliek, 2001). Several members of the 
mitochondrial-shaping protein family are dynamin related proteins (DRPs), that  
are required to maintain mitochondrial morphology via a balance between 
continuous fusion and fission. DRPs are a special class of GTPases, well conserved 
between yeast, flies, and mammals (Hoppins et al., 2007), by hydrolyzing GTP they 
provide the mechanical forces necessary for fusion and division of two lipid bilayer 
that surround mitochondria. Mitochondria-shaping proteins impinge on the 
equilibrium between fusion and fission, thus controlling mitochondrial shape 
transition and form the core morphogenesis machinery. 
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Figure 2 -Mitochondrial networks and fusion fission (A) Three-dimensional 
reconstruction of a mitochondrial network (green) in a Saccharomyces cerevisiae (B) 
Fluorescently labeled mammalian mitochondrial network in a cultured fibroblast cell from 
an African green monkey. Adapted from Westerman et al., 2002 (C) cartoon depicting the 
structure of mitochondrial network in S.cerevisiae and the relative mitochondrial shaping 
proteins regulating fusion and fission processes. Adapted  from Mozdy A et al. J Cell Biol 
2000 (D) cartoon depicting the different shape of mitochondrial network in mammals and 
the dynamin related proteins that regulate these processes  
 
3.3.1 Mitochondrial-fission proteins 
 
3.3.1.1 Dnm1/ DLP1/ DRP1 
 
The key component of the mitochondrial fission machinery in mammals is 
constituted by the cytoplasmic dynamin-related protein 1 (DRP1) (Smirnova et al., 
2001). Dnm1 in yeast, DRP1 in Caenorhabditis elegans and dynamin-like protein 1 
(DLP1)/DRP1 in mammals are homologues and present similarities with dynamin, a 
large GTPase that participates in membrane scission in multiple endocytic and 
secretory organelles (Praefcke and McMahon, 2004). DRP1 contains a dynamin-
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like-central domain and a carboxy-terminal GTPase effector domain, in addition to 
its amino-terminal GTPase. Intra-molecular interactions between the GTPase and 
GED regions appear to be required for full GTPase and fission activities (Zhu et al., 
2004). Given its similarities with dynamin, DRP1 was proposed to couple GTP 
hydrolysis with mitochondrial membrane constriction and fission (Hinshaw, 1999; 
Smirnova et al., 2001). Althought  DRP1 is a cytosolic protein, it is found in spots on 
mitochondria at sites of constriction of the OMM (Labrousse et al., 1999; Smirnova 
et al., 2001). 
 DRP1 is able to oligomerize in vitro, into ring-like structures after being recruited 
to the OMM by a mounting number of proteins: FIS1, Mff and MID 49 and 51.  
 
3.3.1.2 Fis1/ FIS1 
 
FIS1 is an outer membrane protein homogenously distributed on the surface of 
mitochondria (James et al., 2003). Its amino-terminal domain is exposed to the 
cytosol and forms a tetratricopeptide (TPR)-like domain, predicted to allow 
protein–protein interactions (Suzuki et al., 2003). The carboxy-terminal domain of 
FIS1 possesses a TM domain and a short stretch of amino acids facing the IMS. FIS1 
overexpression induces mitochondrial and peroxisome fragmentation, although 
the protein does not possess any enzymatic activity. FIS1 probably recruits DRP1 to 
punctuate structures on mitochondria during mitochondrial fission, being 
therefore considered the limiting factor in the fission reaction. Accordingly, DRP1 
and FIS1 seem to interact, as judged by crosslinking and co-immunoprecipitation 
(Yoon et al., 2003). Indeed, downregulation of FIS1 only partially diminishes DRP1 
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recruitment to mitochondria (Lee et al., 2004b). This pointed out whether FIS1 is 
the only protein needed for DRP1-dependent fission. In yeast FIS1 orthologue 
displays the same structural properties and is called Fis1. During assembly of the 
yeast mitochondrial fission complex, Fis1 recruits Dnm1 to mitochondria. Although 
a direct physical interaction between Fis1 and Dnm1 has been reported (Wells et 
al., 2007), a third player is essential for mitochondrial fission in yeast – Mdv1 (Tieu 
and Nunnari, 2000) or its paralog Caf4 (Griffin et al., 2005).  
These proteins constitute adaptors, acting as scaffolds for the assembly of 
dynamins on membranes (Koirala et al., 2010). In mammals new fission adaptor 
proteins have recently been discovered. 
3.3.1.3 Mff 
 
In 2008 Van der Bliek and colleagues identified a new fission regulator protein 
named mitochondrial fission factor (MFF). This protein is anchored to the OMM 
with the C-terminal trans membrane domain, extruding the bulk of the N-terminal 
portion containing two short amino acids repeats in the N-terminal half and a 
coiled-coil domain just upstream of the trans membrane domain into the cytosol. 
The N-terminal cytosolic region is the one required for Drp1 recruitment, similarly 
to Fis1. It is able to both control mitochondrial and peroxisome elongation 
(Gandre-Babbe and van der Bliek, 2008) and  its downregulation is able to diminish 
the number of Drp1 puncta on mitochondrial surface (Otera et al., 2010). This 
indicates that  Mff and Fis1 share a similar function but act independently.  
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3.3.1.4 MID49 MID 51 
 
Other components of the mitochondrial fission machinery are the MiD49 and 
MiD51 (also called mitochondrial elongation factor 1) of 49 and 51 KDa 
respectively (Palmer et al., 2013). They are amino-terminally anchored in the 
mitochondrial outer membrane with a cytosolic C-terminus. In contrast with Fis1 
and Mff, both MiD49 and MiD51 are localized exclusively to the OMM and are not 
influencing peroxisome tabulation. Two independent studies have demonstrated 
that MiD49/51 are able to recruit Drp1 to the mitochondrial surface independently 
of other anchor proteins such as Fis1 and Mff (Loson et al., 2013; Palmer et al., 
2013). Moreover MiD overexpression causes mitochondrial elongation which is 
due to a sequestration and consequent inactivation of Drp1 at the OMM with 
consequent unopposed fusion events (Palmer et al., 2013). Finally Fis1, Mff and 
MID49/51 can promote mitochondrial fission by recruiting Drp1 to the OMM. 
These proteins can act independently, but it remains possible that they can 
function together in orchestrating this process. Further studies are needed to 
elucidate whether these anchoring proteins operate in particular cellular types or 
stress conditions.  
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3.3.2 Mitochondrial-fusion proteins 
 
3.3.2.1 Mitofusins, the OMM DRPs 
 
Mitofusins, the DRPs that mediate fusion of OMM, are termed Mfn1 and Mfn2 in 
mammals, Fzo and Marf/Dmfn in flies, FZO-1 in the worm and Fzo1 in budding 
yeast. The first known protein mediator of mitochondrial fusion was discovered by 
Hales and Fuller. They used genetic approaches to identify in Drosophila 
melanogaster fuzzy onions (fzo) gene that encodes  for Fuzzy onions 1 protein, a 
member of mitofusin GTPase family, required for developmentally regulated 
mitochondrial fusion event during spermatogenesis  (Hales and Fuller, 1997). The 
Saccharomyces cerevisiae orthologue of Drosophila Fzo, Fzo1p, is required for 
the mitochondrial fusion during mitotic growth and yeast mating and for the 
maintenance of mitochondrial DNA (Hermann et al., 1998). Besides Fzo1, 
Drosophila melanogaster possesses another mitofusin homologue, the 
mitochondrial assembly regulatory factor (Marf) which is expressed ubiquitously in 
males and females. Muscle tissue specific knock-down of Marf induces 
fragmentation and alteration of mitochondrial ultrastructure (Deng et al., 2008). In 
mammals, two Fzo homologues, Mfn1 and Mfn2, are widely expressed in many 
tissues (Eura et al., 2003; Rojo et al., 2002; Santel et al., 2003). Mfn1 and Mfn2 are 
localized in the OMM, and display similar molecular structure that contains an N-
terminal GTPase domain, two transmembrane domains spanning the MOM, and 
separating two heptad repeat regions (HR1 and HR2) (Chen et al., 2003a; Legros et 
al., 2002; Rojo et al., 2002; Santel and Fuller, 2001; Santel et al., 2003). The C-
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terminal HR2 functions in mitochondrial tethering. Specifically when Mfn1 and 2 
form homodimers or heterodimers to tether the outer membranes of adjacent 
mitochondria together, the HR2 region mediates mitofusin oligomerization by 
assembling a dimeric, antiparallel coiled coil. Two MFNs on opposing membranes 
can bind in trans to bridge mitochondria, maintaining a distance of 95 Å between 
the two membranes (Koshiba et al., 2004). The GTPase domain is required for the 
fusion process. It has been shown that Mfn1 exhibits much higher GTPase activity 
compared with Mfn2 during GTP-dependent membrane tethering, although its 
affinity for GTP is lower. In agreement with this, MFN1 exhibits a higher capacity to 
induce fusion (Chen et al., 2003a). In addition,  a genetic analysis revealed that 
OPA1 requires MFN1 but not MFN2 to induce mitochondrial fusion, showing the 
first functional differences between the two mitofusins (Cipolat et al., 2004).  
It has been suggested that Mfn1 is the main tethering protein, whereas Mfn2 may 
have a regulatory role (Detmer and Chan, 2007). Cell lines deficient for Mfn1 and 
Mfn2  completely lack mitochondrial fusion and show severe cellular defects, 
including poor cell growth, widespread heterogeneity of mitochondrial membrane 
potential, and decreased cellular respiration (Chen et al., 2005b). Knockout mice 
for either Mfn1 or Mfn2 die in midgestation, indicating that these genes are 
essential for embryonic development (Chen et al., 2003a). While mitofusins are 
known as mitochondrial fusion proteins, they may be involved in other cellular 
functions. Mfn2 may function as a cell proliferation suppressor, which is 
independent of its mitochondrial fusion activity (Chen et al., 2014). Furthermore 
our laboratory demonstrated a role for Mfn2 in regulating the shape of the 
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endoplasmic reticulum (ER) and as the first molecularly identified tether between 
mitochondria and the ER. Mfn2 is also enriched at the endoplasmic reticulum (ER)-
mitochondria interface, where it tethers ER to mitochondria and facilitates their 
interaction for efficient mitochondrial calcium uptake (de Brito and Scorrano, 
2008). Mutations in MFN2 are responsible for Charcot-Marie-Tooth 2A (CMT2A) 
(Zuchner et al., 2004) an inherited neuropathy characterized by moderate 
weakness and wasting of tibial muscles with lower limb hyporeflexia and mild 
distal sensory loss (Lawson et al., 2005). Most MFN2 mutations in CMT2A cluster 
within the GTPase and the p21RAS-binding domains and are missense mutations 
(Lawson et al., 2005; Zuchner et al., 2004; Kijima et al., 2005). More recently 
mutations in MFN2  has been found to be responsible for mitochondrial DNA 
instability and optic atrophy ‘plus’ phenotype (Rouzier et al., 2012). 
 
 
3.3.2.2 OPA1 an IMM DRP 
 
Since this thesis aims at characterizing the role of OPA1 in vivo, we will discuss this 
protein in details. 
Optic Atrophy 1 (OPA1), the mammalian homologue of S.cerevisiae Mgm1p, is the 
only dynamin related protein so far identified in the mitochondrial inner 
membrane (Olichon et al., 2002). Its name stems from its implication in autosomal 
dominant optic atrophy (ADOA), which affects retinal ganglion cells and the axons 
forming the optic nerve, leading to progressive visual loss (Delettre et al., 2000; 
Alexander et al., 2000).   
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Gene structure 
 
Human and mouse OPA1 gene display a very high homology level (~90%) (Delettre 
et al., 2000). Human OPA1 ORF is built from 30 exons (31 exons in the case of 
mouse) distributed across more than 90 kb of genomic DNA on chromosome 3q28-
q29 (chromosome 1 6 B2; 16 20.65 cM for mouse). OPA1 is expressed 
ubiquitously, with the highest levels in retina, brain, liver, heart and pancreas 
(Alexander et al., 2000; Delettre et al., 2000; Misaka et al., 2002). Human Opa1 
exhibits 8 transcripts which differ in their 3’ UTR and result from the alternative 
splicing of exons 4, 4b and 5b. The relative abundance of these eight OPA1 splice 
variants shows tissue specificity (Delettre et al., 2001; Olichon et al., 2007a; 
Guillery et al., 2008). However, unlike in humans, in mouse only exons 4b and 4a, 
(and not exon 4) are involved in alternative splicing, leading to only 4 splice 
variants (Akepati et al., 2008). Of note, in lower eukaryotes such as in 
invertebrates, no alternative splicing has been reported for OPA1 orthologous 
genes (Olichon et al., 2007a).  
Protein structure 
 
OPA1 mRNA variants encode proteins of 924-1014 amino-acids. OPA1, and its 
yeast orthologues, belongs to the dynamins family, with which it shares three 
conserved regions: a GTPase domain, a middle domain, and a carboxy-terminus 
coiled-coil domain predicted to act as a GTPase effector. The latter is involved in 
the oligomerization and activation of the dynamins. The amino-terminal region of 
OPA1, preceding the GTPase domain, harbors a mitochondrial import sequence 
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(MIS)(Olichon et al., 2002). This MIS is followed by a transmembrane domain 
(TM1) required to anchor  OPA1 to the inner mitochondrial membrane (IMM). 
Next, the splicing region, and in particular the domains corresponding to exons 4b 
and 5b , which are specific to vertebrate, encode a second (TM2a) and a third 
transmembrane domain (TM2b) plus a coiled coil domain (CC). CC0 is involved in 
hetero interaction with CC1. CC1 is located downstream of the alternatively 
spliced region and CC2 in the GED could be responsible for the formation of 
homotypic complexes between distinct OPA1 molecules (Duvezin-Caubet et al., 
2007; Olichon et al., 2007a; Akepati et al., 2008; Belenguer and Pellegrini, 2013) 
(Fig.6). In addition to these post-transcriptional regulations, OPA1 expression is 
also regulated at post-translational level. 
 This later includes proteolytic processing of OPA1/Mgm1p. OPA1 precursors 
translated from the eight OPA1 mRNA are targeted to mitochondria through their 
MIS which is cleaved by the mitochondrial processing peptidase (MPP) upon 
import, to give rise to long isoforms (L-OPA1) (Olichon et al., 2002; Satoh et al., 
2003). Each L-OPA1 is then subjected to a limited proteolysis generating one or 
two short isoforms (S-OPA1) (Song et al., 2007). In physiological conditions, 50% of 
the L-isoforms containing exon 4 and 5b peptides, and 100% of L-isoforms 
containing exon 4b peptide are cleaved in S-isoforms, thus eliminating TM1 
domain and those included in exon4b and 5b domains. Both short and long 
isoforms of OPA1 are associated to mitochondrial membrane, although it is 
proposed that L-OPA1 is anchored to the IMM while S-OPA1, lacking TM1, is 
peripherally attached to the IMM, a fraction of it having the possibility to diffuse in 
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the inter-membrane space (IMS) and to associate to OMM (Olichon et al., 2002; 
Griparic et al., 2004; Satoh et al., 2003; Ishihara et al., 2006; Cipolat et al., 2006).  
Several studies have suggested that three mitochondrial proteases are involved in 
S-OPA1 generation, via two cleavage sites: S1 and S2. First, the rhomboid protease 
PARL (the mammalian counterpart of Pcp1p that cleaves Mgm1p) participates to 
the generation of low abundant S-OPA1 isoforms soluble in the IMS (Cipolat and 
Scorrano, 2006). Its knock-down/out does not affect however the ratio of L- to S-
OPA1. The matricial AAA (m-AAA) metalloprotease paraplegin was proposed to 
cleave OPA1 at S1. Duvezin-Caubet and colleagues in 2007 demonstrated that the 
protease involved in OPA1 processing in not paraplegin, but subunits of the m-AAA 
metalloprotease isozymes complex composed of murine Afg3l1, Afg3l2, or human 
AFG3L2 and SPG7 subunits (Duvezin-Caubet et al., 2006; Duvezin-Caubet et al., 
2007; Ishihara et al., 2006; Griparic et al., 2007; Guillery et al., 2008). In addition, 
prohibitins, regulators of m-AAA proteases activity, are also regulating OPA1 
processing (Merkwirth et al., 2008). Finally, it was shown that the intermembrane 
space AAA (i-AAA) metalloprotease YME1L is responsible for cleavage at S2, but 
interestingly, exon 4b and 5b seem also to present an additional cleavage site for 
the i-AAA Yme1L  (Song et al., 2007; Griparic et al., 2007). 
To make this picture even more complex, it has been shown that dissipation of 
mitochondrial membrane potential and  induction of apoptosis are able to 
stimulate the cleavage of OPA1 (Ishihara et al., 2006; Song et al., 2007; Griparic et 
al., 2007; Guillery et al., 2008). OMA1 an ATP-independent peptidase converts long 
into short OPA1 under these stress conditions (Ehses et al., 2009).  
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Figure 6 -  Schematic representation of OPA1 structure. OPA1 shares several structural 
features with dynamins. These include a GTPase domain containing the three consensus 
GTP binding sequences (red bars) and the dynamin signature (red hatched bar), a middle 
domain and a GTPase effector domain (GED) containing a coiled-coil region (CCII). Before 
the GTPase domain, Opa1 displays amitochondrial import sequence (MIS) followed by a 
predicted transmembrane region (TM1), hydrophobic segments (TM2a and TM2b), and 
coiled-coil regions (CC). These domains are found in OPA1 all splice variants while TM2a, 
TM2b, and CC-0 are only present in spliced exons 4b and 5b. OPA1 exons (numbers) are 
schematized by double arrow. Intra-mitochondrial proteolytic cleavage sites for 
mitochondrial processing peptidase (MPP), paraplegin (S1) and YME1L (S2) are indicated. 
From (P. Belenguer, L. Pellegrini / Biochimica et Biophysica Acta  2012) 
 
OPA1 functions  
 
Involvement in mitochondrial fusion 
OPA1 orthologues in yeast were initially identified as actors involved in 
maintaining the mitochondrial network fused (Guan et al., 1993; Pelloquin et al., 
1999). A similar function was also reported for OPA1. Indeed, silencing all OPA1 
variants, or those specifically including exon4, by RNAi or gene knock-out causes 
fragmentation of the tubular mitochondrial network (Cipolat et al., 2004; Griparic 
et al., 2004; Song et al., 2009). 
 Conversely, OPA1 overexpression induces mitochondrial elongation in cells with 
punctuated mitochondria (Cipolat et al., 2004), but surprisingly, promotes 
fragmentation in cells with tubular mitochondria, suggesting that very high OPA1 
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levels counteract its physiological pro-fusion activity (Misaka et al., 2002) This 
could be explained by two non-exclusive phenomena: 1) the disruption of the 
mitochondrial membrane potential, which is required for the fusion process 
(Legros et al., 2002), and 2) OPA1 interaction with OMM pro-fusion partners: Mfn1 
and Mfn2 (Cipolat et al., 2004; Guillery et al., 2008), thus affecting the fusion 
machinery. The profusion activity of OPA1 was confirmed by experiments showing 
that mitochondrial fusion is impaired in OPA1 depleted cells (Song et al., 2007; 
Song et al., 2009; Cipolat et al., 2004; Chen and Chan, 2005; Lee et al., 2004a). 
Interestingly, both L- and S- forms are required for mitochondrial fusion, each one 
having separately little activity (Song et al., 2007). In addition, a functional role for 
exon 4 peptide has been revealed in the maintenance of mitochondrial membrane 
and fusion of the mitochondrial network (Davies et al., 2007).  
Furthermore, levels of OPA1 can differentially induced two types of fusion: a 
transient fusion that results in rapid exchange of soluble components without 
affecting the mitochondrial morphology, and a complete fusion that allows the 
exchange of all mitochondrial components and affects its morphology (Liu et al., 
2009).  
It is important to note that while loss of OPA1/Mgm1p ultimately leads to 
mitochondrial fragmentation, data obtained in yeast and mammals indicate that 
consistent to its localization, OPA1 functions primarily in fusion of the inner 
membrane. Thus, OPA1 depletion does not abolish OM fusion both in vitro and ex 
vivo.  
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Furthermore multi-matrix structures accumulation reflecting OMM fusion without 
IMM fusion have been revealed by EM in Opa1-/- cells (Song et al., 2009; Meeusen 
et al., 2006). 
It was recently reported that OPA1 pro-fusion activity is crucial for a mitochondrial 
quality control process, the so-called “kiss-and-run” process that involves transient 
fusions between mitochondria. Mitochondria that are affected for OPA1 activity, 
with consequently reduced fusion competency and low membrane potential, will 
be destinated to an active degradation by autophagy (Twig et al., 2008). 
Conversely, excess of OPA1 fusion activity, although transiently protective for 
some specific stresses (Tondera et al., 2009), leads to a senescence process, when 
sustained, by over-production of oxygen species and mitochondrial genome 
damage (Lee et al., 2007). 
 
Involvement in energetic metabolism 
As the IMM is structured in cristae and in a layer facing the OMM called inner 
boundary membrane, it has been suggested that OPA1 provides a dynamic intra-
mitochondrial skeleton, a function that has been postulated in yeast for Mgm1p in 
relation with the oligomerization of ATP synthase (Amutha et al., 2004; Paumard 
et al., 2002; Arselin et al., 2004). Consistent with this implication, OPA1/Mgm1 is 
localized on cristae, as confirmed both by biochemical experiments (Griparic et al., 
2004; Olichon et al., 2003; Pelloquin et al., 1999; Wong et al., 2000) and immuno-
EM (Misaka et al., 2002; Olichon et al., 2002; Satoh et al., 2003; Vogel et al., 2006). 
Furthermore, it has been shown that OPA1 might be involved in cristae 
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maintenance since EM analysis of Mgm1/OPA1-depleted cells showed 
disorganized cristae with irregular shape, and for some of them presenting large 
cristae junctions (Olichon et al., 2003; Griparic et al., 2004; Sesaki et al., 2003). In 
2006, our laboratory demonstrated that Opa1 depleted cells reveal profoundly 
disorganized IMM structure with misshapen baggy cristae, whereas oligomers that 
contain a soluble and a membrane-bound form of OPA1 keep the cristae junctions 
tight, independently from OPA1 role in fusion (Frezza et al., 2006; Cipolat et al., 
2006) RNAi depleted OPA1 cells show a severe reduction of endogenous 
respiration, no stimulation upon addition of an uncoupler and a diminution of 
oxygen consumption driven by complexes I, II and IV of the respiration complex 
(Chen et al., 2005a). In addition, it has been shown that OPA1 physically interact 
with Complex I, II and III of the respiration complex (Zanna et al., 2008). 
 We therefore investigated the role of OPA1 in cristae shape and mitochondrial 
respiratory chain assembly in vivo showing that conditional ablation of Opa1 alters 
cristae shape and respiratory chain supercomplexes assembly, whereas OPA1 
overexpression increases RCS assembly (see results). 
 
Involvement in the control of apoptosis 
In addition to mitochondrial fragmentation, downregulation of OPA1, or 
expression of pathogenic mutants, increases cell sensitivity to spontaneous and 
induced apoptosis (Song et al., 2009; Lee et al., 2004b; Olichon et al., 2007b). 
These observations lead to propose that OPA1 functions as an anti-apoptotic 
protein, providing link between mitochondrial dynamics, energetic metabolism 
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and apoptosis. Indeed, overexpression of OPA1, protects cells from death induced 
by intrinsic signal, independently of its pro-fusion activity by inhibiting cytochrome 
c release (Frezza et al., 2006). Uncoupling  of fusogenic and  apoptotic functions of 
OPA1 could also be observed  upon knockdown of particular splice variants, 
revealing that isoforms containing exon 4 peptide are important for fusion 
whereas those containing either exon 4b or 5b regulate cytochrome c release 
(Olichon et al., 2007a). In addition, OPA1 can regulate cristae morphology 
organizing into high molecular weight complexes that are target by BID during 
apoptosis. This correlates with the remodeling of the cristae that occurs during 
apoptosis (Scorrano et al., 2002; Frezza et al., 2006; Sun et al., 2007). Other studies 
have also implicated OPA1 in the sequestration of cytochrome c within the cristal 
space (Frezza et al., 2006; Yamaguchi et al., 2008).  
This ability of OPA1 to sequester the cytochrome c is attributed to the existence of 
OPA1-containing complexes that maintain the diameter of cristae junctions in a 
basal state enough to retain cytochrome c within the intracristal space.  It has also 
been proposed that OPA1 complexes at the junctions may act as a diffusion barrier 
(Perkins et al., 2009). Upon incubation with BH3-only proteins, OPA1 complexes 
rapidly dissociate, leaving holes large enough to allow the mobilization of 
cytochrome c from the cristae store to the IMS and subsequent release into the 
cytosol. This release could be counteracting upon OPA1 overexpression (Frezza et 
al., 2006). Interestingly, Baricault and colleagues demonstrated that apoptosis 
induction and PTP opening, as well as DeltaPsi(m) dissipation induce OPA1 
cleavage. Decreased mitochondrial ATP levels, generated by apoptosis induction, 
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depolarization or inhibition of ATP synthase appear as the common and crucial 
stimulus that controls OPA1 processing (Baricault et al., 2007).  
 
Involvement in mtDNA maintenance 
OPA1 has also been involved in mtDNA stability. Missense mutations in OPA1 
cause accumulation of multiple deletions in skeletal muscle (Amati-Bonneau et al., 
2008; Hudson et al., 2008). In yeast, early works proposed that mgm1-1 
temperature sensitive mutant leads to a defect in mtDNA synthesis leading to a 
diminution of the number of molecules per cell at each division (Jones and 
Fangman, 1992; Pelloquin et al., 1999). It is proposed that it is through the changes 
in cristae morphology, that OPA1 inactivation perturbs mtDNA anchoring to the 
IMM and thus influences its replication and expression (Hudson et al., 2008). 
Unravelling the mechanisms by which OPA1 may affect mtDNA integrity will be 
another major challenge. 
Thus, OPA1 has distinct function in the regulation of mitochondrial network 
morphology, organelle dysfunction and inner membrane cristae structure. 
 
3.4 Mitochondrial shape and apoptosis  
Mitochondria continually fuse and divide to form a dynamic interconnected 
network. This network disintegrates during apoptosis at the time of cytochrome c 
release, and upstream to caspase activation. Mitochondria fragment giving rise to 
numerous and smaller mitochondria, and undergo cristae remodeling to achieve 
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complete release of cytochrome c. (Frank et al., 2001; Scorrano et al., 2002; Suen 
et al., 2008). The regulation of mitochondrial morphology is a key factor in the 
process of apoptosis, and mitochondria shaping proteins seems to play a role.  
Mitochondrial fission represent a key step in apoptosis. In the early stages of 
apoptosis, DRP1 translocates from the cytosol to mitochondria there is required 
for the  apoptotic mitochondrial fragmentation, before the release of cytochrome 
c. Inhibition of DRP1 by overexpression of a dominant-negative mutant suppress 
apoptosis and prevent cytochrome c release (Frank et al., 2001). Another study 
showed that downregulation of DRP1 delays but does not inhibit completely  
apoptosis (Estaquier and Arnoult, 2007). Similarly, FIS1 is also a player in 
apoptosis. Inhibition of FIS1 suppresses apoptosis, while its overexpression  results 
in cytochrome c release and cell death (Lee et al., 2004, James). Conversely 
mitochondrial fusion is blocked during the BAX activation phase of apoptosis  
(Karbowski et al., 2004). Moreover overexpression of MFN1 and MFN2 inhibits  
cytochrome c release by intrinsic stimuli (Sugioka et al., 2004) and downregulation 
of OPA1 results in mitochondrial fragmentation, accompanied by  cytochrome c 
release and mitochondrial dysfunction (Olichon et al., 2003). Mitochondrial 
ultrastructure changes dramatically in the early stages of apoptosis, 
to allow the complete release of cytochrome c (Fig. 7). Two pools of cytochrome c 
are present in the mitochondria. One in the IMS and another is stored in the 
cristae. The IMS is very narrow, the average distance between OM and IM 
boundary membranes is only 20 nm(Frey and Mannella, 2000).  
Accordingly only 15 %-20% of total cytochrome c is available in the IMS (Bernardi 
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and Azzone, 1981). The major part of cytochrome c is stored in the cristae 
compartment where the oxidative phosphorilation takes place, and is separated by 
IMS by narrow tubular junctions (Frank et al., 2001) The pathway of cristae 
remodeling is characterized by the widening of the narrow tubular junction and 
fusion of individual cristae, with subsequent cytochrome c mobilization from the 
cristae compartment towards the IMS and eventually to the cytosol (Scorrano et 
al., 2002; Germain et al., 2005; Mootha et al., 2001). The mitochondrial shaping 
protein OPA1 seems to play a key role in the regulation apoptotic cristae 
remodeling. OPA1 forms oligomers that participate in formation and maintenance 
of cristae junctions. During apoptosis these complexes are disrupted leading to 
widening of  cristae junctions  and subsequent redistribution of cytochrome c 
(Frezza et al., 2006). 
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Figure 7- schematic (top panel) and representative 3D tomographic reconstruction 
of electron microscopy of mitochondria before (bottom left) or after (bottom right 
panel) induction of apoptosis showing the remodeling of the cristae and the 
consequences on accessibility of cytochrome c to the outer membrane. In the 
bottom panels, cristae are pseudocolored in green, outer membrane in red, inner 
boundary membrane in yellow. From (Scorrano et al., Dev Cell, 2002) 
 
3.5 Mitochondrial shape and atrophy 
Mitochondrial morphology has been shown to be altered during conditions of 
muscle use and disuse. Skeletal muscle  mitochondria form a reticulum which 
increases in response  to endurance training (Kirkwood et al., 1987). In contrast, 
chronic muscle disuse induced by denervation reduces mitochondrial content and 
produces muscle atrophy (Adhihetty et al., 2007). Chronic contractile activity 
induces an increase in mitochondrial content and upregulation of fusion proteins 
in rat skeletal muscle, while on the other side, denervation downregulates fusion 
proteins to a greater extent than the fission proteins (Iqbal et al., 2013). Moreover 
muscles from aged animals showed decrease in mitochondrial content, 
upregulation of fission proteins, and downregulation of fusion protein Mfn1 
without changes in Opa1 levels, that have been shown to be significantly reduced 
in human skeletal muscle with aged related sarcopenia (Joseph et al., 2012). 
Mitochondria dramatically change their shape and dimension during fasting and 
denervation. Overexpression of DRP1 and Fis1 promotes muscle atrophy, while 
inhibition of fission proteins protects from muscle loss (Romanello et al., 2010). 
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 In addition, skeletal muscle specific Mfn1 and Mfn2 deficient mice display severe 
muscle atrophy characterized by mitochondrial dysfunction, loss of mtDNA and 
compensatory mitochondrial proliferation (Chen et al., 2010). Impairment of 
autophagy leads to the accumulation of damaged and dysfunctional mitochondria 
and to a corresponding increase in intracellular ROS levels  (Wu et al., 2009). 
Several conditions involved in muscle atrophy and loss of innervation are 
associated with dramatic increases in mitochondrial production of ROS (Muller et 
al., 2007), that contribute to muscle atrophy by denervation as potent triggers of 
mitochondria-mediated apoptosis (Adhihetty et al., 2007). In conclusion 
mitochondrial dysfunction contributes to muscle atrophy, mainly through increase 
in ROS production, inhibition of protein synthesis and activation of apoptosis. 
 
Figure 8- Scheme that represents the 
effects of mitochondrial fission and 
fusion on signaling pathways that 
control protein degradation systems. 
The dotted line depicts an action 
whose molecular mechanisms and 
role in adult skeletal muscle has not 
yet been completely defined. AMPK 
adenosine monophosphate–activated 
protein kinase; DRP1 dynamin-related 
protein 1; PGC-1α peroxisome 
proliferatoractivated receptor (PPAR)-
γ coactivator-1α; XIAP x-linked 
inhibitor of apoptosis protein. From ( 
Romanello and Sandri 2010). 
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SUMMARY
Respiratory chain complexes assemble into func-
tional quaternary structures called supercomplexes
(RCS) within the folds of the inner mitochondrial
membrane, or cristae. Here, we investigate the rela-
tionship between respiratory function and mitochon-
drial ultrastructure and provide evidence that cristae
shape determines the assembly and stability of RCS
and hence mitochondrial respiratory efficiency. Ge-
netic and apoptotic manipulations of cristae struc-
ture affect assembly and activity of RCS in vitro and
in vivo, independently of changes to mitochondrial
protein synthesis or apoptotic outer mitochondrial
membrane permeabilization. We demonstrate that,
accordingly, the efficiency of mitochondria-depen-
dent cell growth depends on cristae shape. Thus,
RCS assembly emerges as a link betweenmembrane
morphology and function.
INTRODUCTION
Mitochondria are key organelles in intermediate cellular meta-
bolism, energy conversion, and calcium homeostasis (Dimmer
and Scorrano, 2006). They also integrate and amplify apoptosis
induced by intrinsic stimuli, releasing cytochrome c and other
proapoptotic factors required for the activation of caspases
(Green and Kroemer, 2004). Cytochrome c release is regulated
by proteins of the BCL-2 family that control the permeabilization
of the outer membrane (OMM) (Danial and Korsmeyer, 2004).
Energy conversion occurs at the inner mitochondrial mem-
brane (IMM) that can be further divided into two subcompart-
ments: the so-called ‘‘boundary membrane’’ and the cristae,
separated from the former by narrow tubular junctions (Frey
and Mannella, 2000). The cristae shape is dynamic: upon activa-
tion of mitochondrial respiration, ‘‘orthodox’’ mitochondria
become ‘‘condensed,’’ with an expanded cristae space (Hack-
enbrock, 1966). During apoptosis, the curvature of the cristae
membrane is inverted in a remodeling process required for the
complete release of cytochrome c, normally confined in the
cristae (Scorrano et al., 2002; Frezza et al., 2006; Yamaguchi
et al., 2008). Cristae remodeling occurs in response to proapo-
ptotic BH3-only BCL-2 family members, such as BID, BIM-S,
and BNIP3, and independently of the outer membrane multido-
main BCL-2 family members BAX and BAK (Scorrano et al.,
2002; Cipolat et al., 2006; Yamaguchi et al., 2008). Whether
changes in morphology of the cristae, where respiratory chain
complexes (RCCs) mainly localize (Vogel et al., 2006), affect
oxidative phosphorylation efficiency, as originally predicted
(Hackenbrock, 1966), is unclear. This issue is further compli-
cated by the assembly of RCC in supercomplexes (RCS) (Scha¨g-
ger, 1995; Acı´n-Pe´rez et al., 2008), quaternary supramolecular
structures that, by channeling electrons among individual
RCCs, allow the selective use of RCC subsets for nicotine
adenine dinucleotide (NADH)- or flavin adenine dinucleotide-
derived electrons (Lapuente-Brun et al., 2013). Such a supramo-
lecular organization is common in cristae: also, themitochondrial
ATP synthase is assembled into dimers with greater adenosine
triphosphatase (ATPase) activity (Campanella et al., 2008;
Gomes et al., 2011). Interestingly, cristae shape and ATPase
dimers are linked: in yeast mutants where the ATPase cannot
dimerize, cristae are disorganized (Paumard et al., 2002; Min-
auro-Sanmiguel et al., 2005; Strauss et al., 2008), whereas in
mammalian cells, increased cristae density favors ATPase
dimerization during autophagy (Gomes et al., 2011). On the con-
trary, despite their importance in mitochondrial bioenergetics,
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the relationship between RCS and cristae shape remains
unclear.
Mitochondrial morphology and ultrastructure depends on
‘‘mitochondria-shaping’’ proteins that regulate organellar fusion
and fission (Griparic and van der Bliek, 2001). Mitofusins (MFN) 1
and 2, highly homologous dynamin-related proteins of the OMM,
orchestrate fusion (Santel and Fuller, 2001; Legros et al., 2002;
Chen et al., 2003; Santel et al., 2003). MFN1 primarily partici-
pates in fusion, cooperating with the IMM dynamin-related pro-
tein optic atrophy 1 (OPA1) (Cipolat et al., 2004), whereas MFN2
also tethers mitochondria to the endoplasmic reticulum (de Brito
and Scorrano, 2008). Mitochondrial fission is regulated by the
cytoplasmic dynamin-related protein 1 that, upon calcineurin-
dependent dephosphorylation, translocates to mitochondria
(Yoon et al., 2001; Smirnova et al., 2001; Cereghetti et al.,
2008). Genetic depletion of OPA1 leads to disorganization of
the cristae (Frezza et al., 2006), and oligomers that contain a
soluble and a membrane-bound form of OPA1 keep the cristae
junctions tight, independently from OPA1 role in fusion (Frezza
et al., 2006; Cipolat et al., 2006). During apoptosis, these oligo-
mers are early targets of BID, BIM-S, and BNIP3, as well as of
intrinsic death stimuli (Frezza et al., 2006; Yamaguchi et al.,
2008; Landes et al., 2010; Costa et al., 2010). Whereas our
knowledge of the molecular determinants of cristae shape and
their role in apoptosis is increasing, the relationship between
cristae morphology and mitochondrial function remains unex-
plored. We therefore set out to genetically dissect whether and
how cristae shape regulates mitochondrial respiration. We
show that cristae morphology determines assembly and stability
of RCS and hence optimal mitochondrial respiratory function
during life and death of the cell.
RESULTS
Genetic Dissection of Outer Membrane
Permeabilization from Cristae Remodeling
Whether apoptotic cristae remodeling that maximizes cyto-
chrome c release from mitochondria affects mitochondrial func-
tion is unclear, mainly because it occurs around the same time as
outer membrane permeabilization (Scorrano et al., 2002). In
order to genetically dissociate the two processes, we inspected
the primary structure of the prototypical cristae remodeling
inducer BCL-2 family member BID for homology with peptides
known to perturb the mitochondrial inner membrane, like masto-
paran, a 14 amino acid wasp venom component (Pfeiffer et al.,
1995). Interestingly, BID membrane inserting a6 helix as well
as the transmembrane domains of Bnip3 and BimS that also
remodel cristae (Yamaguchi et al., 2008; Landes et al., 2010) dis-
played homology to mastoparan (Figures S1A and S1B available
online). To exploit the role of this homologous sequence in
cristae remodeling, we mutagenized the two highly conserved
157 and 158 Lys H. sapiens BID residues to Ala (BIDKKAA) (Fig-
ure S1C). Because this mutation did not impair caspase-8
cleaved recombinant BID (cBID) integration in purified mouse
liver mitochondria (MLM) (Wei et al., 2000; Figure S1D), we could
measure its biological activity using an established quantitative,
specific cytochrome c release ELISA (Scorrano et al., 2002).
cBID efficiently released cytochrome c from purified mitochon-
dria, whereas a BH3 domain G94E mutant was, as expected,
inactive (Wei et al., 2000) and the cBIDKKAA mutant released
25%–30% more cytochrome c than the baseline (Figure 1A),
a figure close to the amount of free intermembrane space
cytochrome c (Scorrano et al., 2002). BAK oligomerization was
superimposable in cBID or cBIDKKAA-treated mitochondria (Fig-
ure 1B); conversely, two established assays of intramitochon-
drial cytochrome c redistribution, the cytochrome b5-dependent
extramitochondrial NADH oxidation and the ratio of ascorbate-
driven over tetramethyl-p-phenylenediamine (TMPD)-driven
respiration (Scorrano et al., 2002), indicated that cBIDKKAA mobi-
lized the cristae cytochrome c pool less efficiently than cBID
(Figures 1C and 1D). Indeed, cBIDKKAA was unable to remodel
mitochondrial cristae, as indicated by morphometric analysis
of electron micrographs of mitochondria treated with the BID
mutants (Figures 1E and 1F) (Scorrano et al., 2002). Cristae re-
modeling is associated with the disruption of high molecular
weight (HMW) OPA1 oligomers (Frezza et al., 2006). Western
blots of blue native gel electrophoresis (BNGE) of mitochondrial
proteins revealed four major OPA1-containing complexes. Upon
treatment with cBID, OPA1 rapidly disappeared from 720 kDa
HMWcomplexes (Figures 1G, S1E, and S1F). These HMW forms
of OPA1 were similarly targeted by cBIDG94E but significantly
less by cBIDKKAA, as determined by BNGE (Figure 1H, quantifi-
cation in [I]). Chemical crosslinking experiments (Frezza et al.,
2006) further confirmed that the OPA1-containing oligomer is
disrupted by the mutants of cBID able to induce cristae remod-
eling (Figures S1G and S1H). Finally, we measured the killing
efficiency of these truncated BID (tBID) mutants expressed in
mouse embryonic fibroblasts (MEFs). Only tBID efficiently killed
MEFs: tBIDKKAA and tBIDG94E elicited comparable low levels of
cell death, whereas the double tBIDKKAA,G94E mutant appeared
completely ineffective (Figure 1J), suggesting that both outer
membrane permeabilization and mitochondrial cristae remodel-
ing are required for BID-induced apoptosis. In conclusion,
BIDKKAA is deficient in cristae remodeling, cytochrome c release,
and induction of apoptosis.
RCS Disassemble during Cristae Remodeling
The BIDKKAA mutant dissociates outer membrane permeabiliza-
tion from cristae remodeling and can be used to investigate the
relationship between the latter and mitochondrial function. We
therefore measured the effect of the BID mutants on the respira-
tory control ratio (RCR), an index of respiratory efficiency, of
mitochondria incubated with excess exogenous cytochrome c
andNADH (to compensate for the potential effects of innermem-
brane or outer membrane [OM] permeabilization). cBID reduced
RCR only when mitochondria were energized with substrates for
complex I (glutamate/malate) but not when they were fed with
substrates entering the electron transport chain at complex II
(succinate) or complex IV (ascorbate + TMPD) (Figure 2A; data
not shown). Interestingly, these changes were recapitulated by
the BH3 domain mutant cBIDG94E that does not permeabilize
the OM but not by the cristae remodeling-deficient mutants
cBIDKKAA and cBIDKKAA,G94E (Figure 2B). Maximal (uncoupled)
respiration was similarly affected by the cBID mutants tested,
ruling out that BID alters RCR, because it affects ATPase or ac-
tivity or ATP/ADP exchange (Figure S2A). These experiments
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suggest that cristae remodeling causes complex I-dependent
changes in mitochondrial bioenergetics.
Complex I is further assembled in quaternary functional RCS
with complexes III and IV (I + III and I + III + IV), whereas most
complex II is not found in RCS (Acı´n-Pe´rez et al., 2008). Thus,
the reduction in complex I-supported respiration could be a
consequence of specific inhibition of complex I or of issues in
RCS function. Even after 30 min of acute BID treatment, the
specific complex I NADH-ubiquinone reductase activity of puri-
fied mitochondria was unaltered (data not shown), prompting
us to investigate RCS assembly and stability in situ. We therefore
took advantage of Bax/, Bak/ (DKO) MEFs, resistant to
mitochondrial permeabilization, cytochrome c release, and
apoptosis triggered by expression of tBID (Wei et al., 2001).
Upon transduction of metabolically labeled DKO MEFs with
tBID but not with tBIDKKAA that does not cause cristae remodel-
ing (Figure S2B), the RCS radioactivity signal as well as the RCS/
complex V radioactivity ratio were reduced (Figures 2C and 2D),
and we observed a reduction in the autoradiographic signal of
cytochrome b retrieved in RCS compared to that in free complex
III (Figures 2E and 2F). Whereas this result could suggest that
complex III was incorporated less efficiently into RCS, immuno-
blotting for the complex I subunit NDUFA9 revealed that RCSs
were also destabilized in DKO cells (Figure 2G). Functionally,
only cBID and cBIDG94E that cause cristae remodeling but not
cBIDKKAA reduced glutamate-supported RCR in DKO mitochon-
dria (Figure 2H). Thus, BID destabilizes RCS and selectively re-
duces glutamate-dependent RCR.
Figure 1. Two Conserved Lys in BID a6 He-
lix Are Required for Cristae Remodeling
(A) Mitochondria were treated for the indicated
times with the indicated mutants of cBID, and
cytochrome c release was measured by ELISA.
Data represent average ± SEM of five indepen-
dent experiments.
(B) Mitochondria treated with the indicated mu-
tants of cBID for the indicated min were cross-
linked with 1 mM BMH for 30 min, spun, and
the pellets were separated by SDS-PAGE and
immunoblotted using anti-BAK antibody. The as-
terisks denote BAK oligomers.
(C) Mitochondria were treated as indicated (Ca2+,
200 mM), and cytochrome b5-dependent NADH
fluorescence changes were recorded. a.u., arbi-
trary units.
(D) Mitochondria were treated for 15 min with
the indicated BID mutants, transferred into the
chamber of a Clark’s type O2 electrode, and the
ascorbate/TMPD-driven respiration ratio was
determined. Data represent average ± SEM of four
independent experiments.
(E) Representative electron microscopy fields of
mitochondria treated for 15 min with the indicated
cBID mutants. Arrows indicate class II and III
mitochondria. The scale bar represents 450 nm.
(F) Blind morphometric analysis of randomly
selected EM of mitochondria treated with the
indicated cBID mutants (as in [E]). Mitochondria
were assigned to morphological classes I–III as in
Scorrano et al. (2002). Data represent average ±
SEM of three independent experiments. The
asterisk denotes p < 0.05 in a paired sample
Student’s t test versus untreated.
(G and H) BNGE analysis of OPA1 oligomers in
MLM treated for 30 min (G) or for the indicated
minutes (H), as indicated. The boxed area in-
dicates the HMW complexes of OPA1.
(I) Densitometric analysis of OPA1 HMW com-
plexes. Experiments were as in (H). Data represent
average ± SEM of four independent experiments.
(J) MEFs were transfected with the pMIG plasmid
containing the indicated insert and after 48 hr cell
death was determined cytofluorimetrically as the
percentage of Annexin-V+, GFP+ cells. Data
represent average ± SEM of four independent
experiments. The asterisk denotes p < 0.05 in a
paired sample Student’s t test versus tBID.
See also Figure S1.
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Conditional Ablation of Opa1 Alters Cristae Shape and
RCS Assembly
To verify whether RCS disorganization was a general conse-
quence of altered cristae shape, we turned to cells lacking
Opa1, a key regulator of cristae morphology (Frezza et al.,
2006). However, chronic Opa1 depletion impaired mitochondrial
DNA (mtDNA) levels and translation (Figures S3A and S3B),
complicating the analysis of the relationship between Opa1
and RCS and calling for a model of conditional Opa1 ablation.
We produced, by homologous recombination, C57BL6/J
Figure 2. Respiratory Chain Supercomplexes Are Disassembled during Cristae Remodeling
(A) RCR of mitochondria energized with 5 mM/2.5 mM glutamate/malate (GLU/MAL) or 10 mM succinate (SUCC) treated for the indicated times with cBID. Data
represent average ± SEM of five independent experiments. Inset, RCR values normalized to t = 0.
(B) Experiments were as in (A), except that mitochondria were incubated with the indicated mutants of cBID for 15 min. Data represent average ± SEM of four
independent experiments. The asterisk denotes p < 0.05 in a paired sample Student’s t test versus untreated.
(C) BNGE of mitochondrial OXPHOS protein from DKOMEFs transduced as indicated and, after 2 days, metabolically labeled for 2 hr and lysed after 24 hr. Equal
amounts of protein (100 mg) were separated by BNGE, and radioactivity was detected in the fixed and dried gels for 1 week. RCC and RCS of the respiratory chain
are indicated.
(D) Densitometric analysis of the autoradiographic RCS/complex V signal ratio. Data represent average ± SEM of three independent experiments performed as in
(E). The asterisk denotes p < 0.05 in a paired sample Student’s t test versus untreated.
(E) 2D BN/SDS PAGE analysis of mitochondrial OXPHOS proteins from DKOMEFs transduced as indicated, metabolically labeled for 2 hr, and lysed after 24 hr.
Equal amount (50 mg) of proteins were separated in native condition, and then the lanes were excised and proteins separated by a second dimension SDS-PAGE.
The gels were dried and the signal was detected following 1 week of exposure. RCC and RCS of the respiratory chain as well as the single-labeled proteins are
indicated. Boxes and circles indicate RCS and cytochrome b, respectively.
(F) Densitometric analysis of the ratio of autoradiographic signal between supercomplex (boxed) and complex assembled cytochrome b (circled). Data represent
average ± SEM of three independent experiments. The asterisk denotes p < 0.05 in a paired sample Student’s t test versus untreated.
(G) BNGE analysis of OXPHOS proteins in mitochondria from DKO MEFs transduced as indicated. Equal amounts (100 mg) of proteins were separated in native
conditions, transferred onto PVDF membranes, and probed with the indicated antibodies. RCC and RCS are indicated.
(H) RCR of DKO mitochondria energized with 5 mM/2.5 mM GLU/MAL or 10 mM SUCC treated for 15 min with the indicated cBID mutants. Data represent
average ± SEM of four independent experiments. The asterisk denotes p < 0.05 in a paired sample Student’s t test versus untreated.
See also Figure S2.
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embryonic stem cells with loxP sites inserted in the Opa1 gene
(Opa1flx/flx), which were then microinjected in C57BL6/J blasto-
cysts to generate Opa1flx/flx mice. Following Cre-mediated
recombination, the deletion of exons 2 and 3 resulted in an aber-
rant exon1–exon4 transcript with a stop codon immediately after
exon 1, producing a predicted 10 amino acid (aa) residual protein
(Figures 3A and 3B). Chimerism and germ-line transmission of
the offspring was tested by PCR, and germ-line transmittants
were bred to homozygosity (Figure 3C). Fibroblasts isolated
from the diaphragm of homozygous Opa1flx/flx 7-week-old
male mice (MAFs) were immortalized and used for subsequent
analysis. OPA1 was completely ablated 24 hr after adenoviral
delivery of Cre recombinase (Figure 4A) and, as expected, mito-
Figure 3. Generation of Opa1flx/flx and
Opa1tg Mice
(A) Maps of the wild-typeOpa1 allele, the targeting
vector, the conditional floxed allele, and the in-
activated Opa1 allele. The 50 UTR, exons (black
boxes), LoxP sites (white arrows), FRT recombi-
nation sites, and PGK-neomycin cassette (white
box) are indicated. The locations of PCR primers
(ck1 = primer check1 forward, ck2 = primer check2
reverse) are indicated. Dimensions are not in scale.
(B) Prediction of the maximal possible aberrant
OPA1 protein.
(C) RT-PCR analysis of transcripts in heterozy-
gous (flx/), homozygous (flx/flx), and WT mice.
(D) Maps of the targeting vector, the mutant Hprt
locus of BPES cells, and the transgenic targeted
and functional Hprt locus. The 50 UTR, the human
b-ACTIN promoter andOpa1 gene (light gray box),
poly A (white box), human exon 1 ofHprt locus (h1,
dark gray box), and Hprt locus exons (black
boxes) are indicated. The locations of PCR
primers (WTF, WT forward; WTR, WT reverse; tgF,
transgenic forward; tgR, transgenic reverse) are
indicated. Dimensions are not in scale.
(E) RT-PCR screening of ESC clones. The positive
clones are indicated.
(F) RT-PCR analysis of transcripts in heterozygous
(tg/), homozygous (tg/tg), and WT mice.
See also Figure S3.
chondria were fragmented (Figures 4B
and 4C) with defects in cristae shape (Fig-
ures 4D and 4E). Four days after Cre-
mediated Opa1 ablation, mtDNA copy
number (Figure 4F) and translation (Fig-
ures 4G and 4H) were unaffected, allow-
ing us to specifically address the role of
OPA1 and cristae shape in RCS assembly
using an assay based on the incorpora-
tion of radiolabeled mtDNA-encoded
proteins into RCC and RCS (Acı´n-Pe´rez
et al., 2008). Upon acute Opa1 ablation,
the assembly of mtDNA-encoded sub-
units into RCC was not affected (data
not shown). We therefore followed the
RCS assembly rate (measured as the
ratio between RCS and complex V radio-
activity throughout the chase period) that resulted 8-fold
slower when Opa1 was ablated from Opa1flx/flx MAFs (Figures
4I and 4J). A similar reduction in the RCS assembly rate was
observed in Opa1/ MEFs (Figure S3C), suggesting that, in
absence of Opa1, RCC are less superassembled, irrespective
of their initial levels. To test if acute Opa1 ablation altered RCS
in vivo, we tail vein-injected Cre-expressing adenoviruses in
Opa1flx/flx animals. After 72 hr, OPA1 levels in liver mitochondria
were reduced by 50% (Figure S4A), cristae morphology was
abnormal (Figure S4B), RCS were reduced (Figure S4C), and
glutamate/malate RCR was impaired (Figure 4K). These experi-
ments of conditional ablation of Opa1 identify a role for cristae
shape in RCS assembly in vitro and in vivo.
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Overexpression of Opa1 Increases RCS Assembly
The model linking cristae shape to RCS predicts that higher
OPA1 levels should favor RCS assembly. To verify this hypo-
thesis, we wanted to generate a mouse model of Opa1
overexpression. Very high OPA1 levels are, however, toxic,
causing paradoxical mitochondrial fragmentation (Cipolat
Figure 4. Acute Ablation of Opa1 Alters Mitochondrial Morphology, Cristae Shape, and RCS Assembly
(A) Opa1flx/flx MAFs were infected with bicistronic adenoviruses carrying the indicated insert (EV, empty vector; CRE, Cre recombinase) upstream of GFP and,
after 24 hr, equal amounts of proteins (20 mg) were separated by SDS-PAGE and immunoblotted with the indicated antibodies.
(B) Opa1flx/flx MAFs were infected with the indicated adenoviruses and, after 24 hr, fixed, immunostained using an anti-TOM20 antibody, and representative
confocal images acquired. The green cytoplasmic staining identifies the coexpression of GFP. The scale bar represents 20 mm.
(C) Average mitochondrial major axis length. Experiments were as in (B). Data represent average ± SEM of four independent experiments (five mitochondria per
cell, at least 50 cells/experiment). The asterisk denotes p < 0.05 in a paired sample Student’s t test versus ad-EV.
(D) Opa1flx/flx MAFs were infected with the indicated adenoviruses and, after 24 hr, fixed and processed for electron microscopy. The scale bars represent 2 mm
(top) and 200 nm (bottom).
(E) Morphometric analysis of cristae width in 40 randomly selected mitochondria of Opa1flx/flx MAFs infected with the indicated adenoviruses. Data represent
average ± SEM of three independent experiments. The asterisk denotes p < 0.05 in a paired sample Student’s t test versus ad-EV.
(F) Mitochondrial DNA copy number quantification. mtDNAwas amplified by RT-PCR from total DNA ofOpa1flx/flxMAFs infected with the indicated adenoviruses.
Data are normalized to MAFs infected with control adenovirus and represent average ± SEM of four independent experiments.
(G) mtDNA translation assay.Opa1flx/flxMAFs infected as indicated weremetabolic labeled in presence of emetine and lysed after 30min. Protein samples (40 mg)
were separated by SDS-PAGE, and the radioactivity was detected in the fixed and dried gels for 3 days. The mtDNA encoded proteins are indicated.
(H) Densitometric analysis of the mtDNA-encoded proteins. Experiments are as in (G). Data represent average ± SEM of four independent experiments.
(I) RCS assembly assay.Opa1flx/flxMAFs were infected as indicated and, after 24 hr, metabolically labeled for 2 hr and then chased for the indicated times. Equal
amounts of protein (100 mg) were separated by BN PAGE, and radioactivity was detected in the fixed and dried gels for 1 week. RCC and RCS of the respiratory
chain are indicated.
(J) Densitometric analysis of the incorporation rate of radioactivity into supercomplexes. Values are normalized for the autoradiographic signal of complex V. Data
represent average ± SEM from three independent experiments performed as in (H).
(K) RCR of mitochondria isolated from livers of Opa1flx/flx mice 3 days after tail-vein injection of the indicated adenoviruses, energized with 5 mM/2.5 mM GLU/
MAL or 10 mM SUCC. Data represent average ± SEM of four independent experiments. The asterisk denotes p < 0.05 in a paired sample Student’s t test versus
ad-EV.
See also Figure S4.
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et al., 2004): we therefore targeted, by homologous recombina-
tion in the murine X chromosome Hprt region, a transgene-car-
rying mouse variant 1 Opa1 under the human b-actin promoter
(Opa1tg) (Figure 3D). The integration into microinjected BPES
embryonic stem cells was verified by PCR (Figure 3E), and the
cells were microinjected into C57BL6/J blastocysts. Six gener-
ated agouti chimeras with a chimerism exceeding 90% were
bred with C57BL6/J mates and tested for germline transmission
by fur color and transgene PCR analysis (Figure 3F). Mice were
viable, fertile, grew normally, and resisted to different forms of
tissue damage (T.V., M.E.S., V. Romanello, S.C., V.C., R. Me-
nabo`, M. Sandri, F. Di Lisa, and L.S., unpublished data). Immor-
talized MAFs prepared from the diaphragm of hemizygous
Opa1tg 7-week-old C57BL6/J male mice displayed an 1.5 in-
crease in OPA1 levels compared to age- and sex-matched litter-
mate controls MAFs (wild-type [WT]; Figure 5A). Mitochondria
were slightly elongated (Figures 5B and 5C) and cristae tighter
(Figures 5D and 5E), without any difference in mtDNA levels (Fig-
ure 5F) and translation (Figures 5G and 5H). Importantly, in
Opa1tg MAFs, RCS assembly (Figures 5I and 5J) and gluta-
mate-supported RCR (Figure 5K) were increased. In vivo, an
50% increase in liver mitochondria OPA1 levels (Figure S5A)
was similarly associated to tighter cristae (Figure S5B) and
increased RCS levels (Figure S5C). Taken together, these results
indicate that RCS assembly is facilitated by increased OPA1
levels and tighter cristae.
Mitochondria-Supported Cell Growth Is Controlled by
Cristae Shape
We next wished to address if cristae shape affects mitochon-
drial-dependent cell growth. We therefore measured the growth
of DKO cells (resistant to BID-induced outer membrane per-
meabilization, caspase-dependent mitochondrial damage, and
apoptosis) in galactose media, where most of cellular ATP
comes from the respiratory chain (Acı´n-Pe´rez et al., 2004). WT
and G94E tBID impaired growth in galactose, whereas cells
transduced with tBIDKKAA that does not cause cristae remodel-
ing did not display any defect (Figure 6A).
We next turned to genetic models of cristae shape changes.
Growth in galactose-containing media was impaired upon acute
ablation of Opa1 in MAFs, whereas it was normal for fusion-defi-
cient Mfn1/, Mfn2/ MEFs (Figures 6B and 6C), where mito-
chondrial fusion is also inhibited. In Mfn1/, Mfn2/ MEFs,
mtDNAcopynumberwas reduced (FigureS6A), but cristae shape
(Figures S6BandS6C),mtDNA translation (Figure S6D), RCS sta-
bility (Figure S6E), and assembly (Figure S6F) were not affected.
Thus, the galactose growth defect is not the consequence of
impaired fusion but correlates with altered cristae shape and
RCS.Finally,Opa1tgMAFsgrew faster than theirWTcounterparts
in galactose media (Figure 6D), further confirming the link be-
tween cristae shape, RCS levels, and mitochondria-dependent
cellular growth. In conclusion, cristae shape correlates with the
efficiency of mitochondria-dependent cell growth.
DISCUSSION
Respiratory chain supercomplexes have been considered BNGE
artifacts until direct respirometric experiments on purified RCS
identified them as the functional mitochondrial respiratory units
(Acı´n-Pe´rez et al., 2008). Since then, RCS have been directly
visualized in intact cristae by electron tomography (Davies
et al., 2011), complex IV assembly factors that favor RCS forma-
tion have been identified (Chen et al., 2012; Vukotic et al., 2012;
Strogolova et al., 2012; Lapuente-Brun et al., 2013), and the role
of RCS in mitochondrial utilization of reducing equivalents has
been demonstrated (Lapuente-Brun et al., 2013). However, the
relationship between cristae shape and RCS, as well as between
RCS and mitochondrial function, remained obscure. Our results
demonstrate that cristae shape regulates respiratory chain
supercomplexes stability and assembly, impacting on respira-
tory efficiency and respiratory cell growth.
To dissect the role of cristae shape in RCS structure and func-
tion, we genetically ablated the master cristae shape regulator
OPA1. Individual respiratory chain units associate with OPA1
(Zanna et al., 2008), and mitochondrial metabolism is deranged
in dominant optic atrophy caused by OPA1 mutations (Lodi
et al., 2004). However, the defect in ATP production in OPA1
haploinsufficient cells was unexplained: OPA1 is not essential
for assembly of respiratory chain complexes and mtDNA levels
as well as activities of individual respiratory chain complexes
are normal in dominant optic atrophy (Zanna et al., 2008).
Conversely, the reduction in mtDNA copy number has been
invoked to explain the mitochondrial dysfunction of fusion-
deficient cells from Mfn1, Mfn2-deficient mice (Chen et al.,
2010). Our results challenge this hypothesis: upon acute Opa1
ablation, mtDNA levels are normal, whereas cristae shape,
RCS, complex-I-dependent respiration, and respiratory growth
are impaired. Conversely, in Mfn1/, Mfn2/ cells, mtDNA
copy number is reduced, but cristae shape, RCS, and respiratory
growth are normal. Thus, RCS disorganization shall be regarded
as a key mechanism of mitochondrial dysfunction accompa-
nying altered organelle morphology.
The role of OPA1 and cristae shape in RCS organization is
further supported bymousemodels ofOpa1 conditional ablation
and mild overexpression. The first tool allowed us to dissociate
cristae biogenesis from mtDNA maintenance: whereas chronic
Opa1 depletion reduces mtDNA copy number and translation,
upon acute Opa1 ablation, mtDNA levels are normal, but cristae
are disorganized, impacting on RCS assembly and respiratory
function and growth. Thus, mtDNA reduction appears to be a
consequence of chronic fusion inhibition inOpa1/ (and double
Mfn/) cells. We can therefore predict that the Opa1flx/flx cells
will be useful to elucidate how prolonged inhibition of mito-
chondrial fusion results in mtDNA levels reduction. Opa1 mild
overexpression lends further support to the model linking RCS
organization to cristae shape: RCS assembly and respiratory
function and growth are increased in Opa1tg cells without any
measurable change in mtDNA levels and translation. TheOpa1tg
mouse will be instrumental to investigate the role of Opa1 and
cristae shape in vivo.
Apoptotic cristae remodeling further supports the relationship
between cristae shape and RCS. The role and mechanisms of
cristae remodeling in apoptosis are controversial (Scorrano
et al., 2002; Germain et al., 2005; Frezza et al., 2006; Yamaguchi
et al., 2008; Merkwirth et al., 2008; Costa et al., 2010). Despite
that OPA1-mediated stabilization of cristae shape inhibits
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intrinsic apoptosis (Frezza et al., 2006; Yamaguchi et al., 2008;
Costa et al., 2010), cristae remodeling has been reckoned as a
mere feedback mechanism in situ, occurring after caspase acti-
vation (Sun et al., 2007). Our results suggest that, in addition to
its role in cytochrome c release, cristae remodeling also impairs
mitochondrial function to precipitate apoptosis. The BID a6
mutant generated here, which does not induce cristae changes
and cytochrome c mobilization but permeabilizes the outer
Figure 5. Transgenic Overexpression of OPA1 Increases RCS Assembly
(A) Equal amounts of proteins (20 mg) from MAFs of the indicated genotypes were separated by SDS-PAGE and immunoblotted with the indicated antibodies.
(B) Representative confocal micrographs of mitochondrial morphology in WT and Opa1tg MAFs. Mitochondria were visualized by anti-TOM20 immunostaining.
The scale bar represents 20 mM.
(C) Average mitochondrial major axis length. Experiments were as in (B). Data represent average ± SEM of four independent experiments (five mitochondria per
cell, at least 50 cells/experiment). The asterisk denotes p < 0.05 in a paired sample Student’s t test versus WT.
(D) Electron micrographs of MAFs of the indicated genotype. The scale bars represent 2 mm (top) and 200 nm (bottom).
(E) Morphometric analysis of cristae width in 40 randomly selected mitochondria of MAFs of the indicated genotype. Data represent average ± SEM of three
independent experiments. The asterisk denotes p < 0.05 in a paired sample Student’s t test versus WT.
(F) Mitochondrial DNA copy number quantification. mtDNA was amplified by RT-PCR from total DNA of MAFs of the indicated genotype. Data are normalized to
WT MAFs and represent the average ± SEM of four independent experiments.
(G) mtDNA translation assay. MAFs of the indicated genotype weremetabolic labeled in presence of emetine and lysed after 30min. Protein samples (40 mg) were
separated by SDS-PAGE, and the radioactivity was detected in the fixed and dried gels for 3 days. The mtDNA-encoded proteins are indicated.
(H) Densitometric analysis of the mtDNA-encoded proteins. Experiments are as in (G). Data represent average ± SEM of four independent experiments.
(I) RCS assembly assay. MAFs of the indicated genotype were metabolically labeled for 2 hr and then chased for the indicated times. Equal amounts of protein
(100 mg) were separated by BN PAGE, and radioactivity was detected in the fixed and dried gels for 1 week. Individual complexes and supercomplexes of the
respiratory chain are indicated.
(J) Densitometric analysis of the incorporation rate of radioactivity into RCS. Values are normalized for the autoradiographic signal of complex V. Data represent
average ± SEM of three independent experiments performed as in (H).
(K) RCR of mitochondria isolated from livers of mice of the indicated genotype energized with 5 mM/2.5 mM GLU/MAL or 10 mM SUCC. Data represent
mean ± SEM of four independent experiments. The asterisk denotes p < 0.05 in a paired sample Student’s t test versus WT.
See also Figure S5.
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membrane, can be a useful tool to dissect in vivo the involvement
of cristae remodeling in developmental and homeostatic
apoptosis. We think that cristae remodeling influences RCS by
targeting OPA1 (Frezza et al., 2006), not by altering membrane
potential that is normal during cristae remodeling (Scorrano
et al., 2002) or by inhibiting mtDNA translation and insertion of
mtDNA-encoded subunits that similarly appear normal in DKO
cell-expressing BID (data not shown).
Our work unravels a role for cristae shape in RCS assembly
and stability, mitochondrial respiratory efficiency, and respira-
tory growth, suggesting that shape of biological membranes
can influence membrane protein complexes. Moreover, our
data highlight the importance of RCS in respiration by complex
I-feeding substrates. Finally, we unveil how OPA1 regulates
mitochondrial respiratory efficiency. The pathogenesis of domi-
nant optic atrophy where OPA1 is mutated (Alexander et al.,
2000) or of other mitochondrial diseases where OPA1 is
degraded (Duvezin-Caubet et al., 2006) could also depend on
this unexpected OPA1 function. In these latter settings, stabiliza-
tion of OPA1 could correct RCS and therefore mitochondrial
dysfunction, opening novel therapeutic perspectives for
currently intractable diseases.
EXPERIMENTAL PROCEDURES
Generation of Opa1flx/flx and Opa1tg Mice
To generateOpa1flx/flxmice, amouse Bac clone containing theOpa1 genewas
isolated from the C57BL/6J ES BAC clone library. An 11 kb HpaI DNA restric-
tion fragment containing the 5 kb upstream-exon3 was subcloned in a pUC-8
vector. The OPA1 fragment was excised with EcoRV and Xmal to generate
blunt ends and inserted into a pKO4.4a-LoxP cut with XhoI and SalI. A LoxP
site was introduced between intron1 and exon2 of Opa1 and a phosphoglyc-
erate kinase (PGK) promoter-driven neomycin resistance gene, flanked by two
FRT sequences and with one LoxP sequence downstream, was inserted in
intron3. The targeting vector was linearized and electroporated into C57BL6
embryonic stem cells (ESCs). Neomycin-resistant ESC clones were tested
for homologous recombination. Three mutated ESC lines were microinjected
into C57BL6 blastocytes and implanted in host mice to obtain chimeric
mice, which were then bred with C57BL6 mates and their offspring tested
by PCR for germline transmission. Colonies were established in a C57BL6
background.
To generate Opa1tg mice, the human b-actin promoter was extracted from
pDRIVE-hb-ACTIN (InvivoGen) using SpeI and NcoI and cloned in pENTRY.
The complementary DNA of mouse isoform 1 Opa1 and polyA extracted
from pcDNA3.1-OPA1 (Cipolat et al., 2004) using Nhe1 and EciI was ligated
into pENTRY using Quick Ligase (Ozyme). The transgene was then inserted
by homologous recombination in a pDEST vector containing part of the human
hypoxanthine phosphoribosyltransferase locus. The resulting vector was
Figure 6. Mitochondria-Dependent Cellular Growth Requires Assembled RCS
(A) Growth curves of DKO MEFs transduced with the indicated retroviruses and grown in DMEM supplemented with the indicated monosaccharides. Data
represent mean ± SEM of five independent experiments.
(B–D) Growth curves of the indicated cell lines cultured in DMEM supplemented with the indicated monosaccharides. Data represent mean ± SEM of five in-
dependent experiments.
See also Figure S6.
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linearized using PvuI and electroporated into C57BL6 BPES cells by Nucleis
(France). Homologous recombinants were selected on stringent hypoxanthine
aminopterin-thymidine-supplemented medium. Three positive ESC recombi-
nant clones were microinjected into C57BL6 blastocysts and implanted into
host pseudopregnant female C57BL6 to obtain chimeric mice. Six chimeras
(identified by fur agouti color) were bred with C57BL6 mates, and germline
transmission was verified by fur color and PCR. Colonies were established
in a C57BL6 and in a Sv129 background by crossbreeding. Details on mouse
genotyping and handling can be found in the Extended Experimental
Procedures.
BNGE, 2D BN/BNGE, and 2D BN/SDS PAGE
Mitochondria (10 mg/ml) were suspended in buffer D (1 M 6-aminohexanoic
acid, 1.25% V/V digitonin, 50 mM Bis-Tris-HCl, pH 7) and centrifuged. The
supernatant was collected, and 5% Serva Blue G dye in 1 M 6-aminohexanoic
acid was added to 1/3 of the final sample volume. Equal amounts (100 mg) of
mitochondrial proteins were separated by 3%–13% gradient BNGE (Scha¨g-
ger, 1995). For RCS detection, the concentration of digitonin in buffer D was
4% (V/V).
For two-dimensional (2D) Blue Native (BN)/BNGE, the lane cut from the first-
dimension BNGE was casted on top of a native 3%–14% gradient gel in 1%
(V/V) dodecyl maltoside. For 2D BN/SDS PAGE, the lane cut from the first-
dimension BNGEwas incubated for 1 hr at 25C in 1%SDS and 1% b-mercap-
toethanol and then casted on top of an 8% or a 16.5% denaturing gel. After
electrophoresis, the complexes were electroblotted on a polyvinylidene fluo-
ride (PVDF) membrane and probed with the indicated antibodies.
To detect RCS from radiolabelled cells, samples were treated as described
above, and after electrophoresis, the gels were dried and the signal was de-
tected following exposure for 3–6 days.
Pulse-Chase Experiments
Labeling of mtDNA-encoded proteins was performed with [35S]-methionine
and cysteine (EXPRE35S35S Protein Labeling Mix, Perkin Elmer Life Sciences).
Cells were preincubated for 12 hr in the presence of 40 mg/ml chloramphenicol
in uridine-supplemented medium and then exposed for 2 hr to the [35S] protein
labeling mix (pulse) in the presence of 50 mg/ml cycloheximide. Cells were
washed for four times with PBS and cold Dulbecco’smodified Eagle’smedium
(DMEM) and then cultured for the indicated time (chase) prior to lysis and pro-
tein separation by BNGE.
To assay basal mtDNA translation, equal protein amounts (40 mg) from cells
metabolically labeled as described above treated for 30 min with 50 mg/ml
emetine were separated by SDS-PAGE.
Mitochondrial Assays
Mitochondria from liver of mice and from the indicated cell lines were isolated
as in Frezza et al. (2007). Cytochrome c release, ascorbate/TMPD-driven
respiration and cytochrome b5-dependent NADH oxidation were determined
as described (Scorrano et al., 2002). Details can be found in the Extended
Experimental Procedures.
Biochemistry
For protein crosslinking, mitochondria treated as indicated were incubated
with 1 mM 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride
(EDC) or 1 mM bismaleimidohexane (BMH), as previously described (Frezza
et al., 2006). Carbonate extraction was performed as previously described
(Dimmer et al., 2008). Details and procedures for SDS-PAGE and immunoblot-
ting can be found in the Extended Experimental Procedures.
Molecular Biology
The retroviral vector pMIG-tBid was described previously (Cheng et al., 2001).
KKAA, G94E, and G94EKKAA mutants were generated by site-direct muta-
genesis using KOD polymerase (Biolabs). Details can be found in the Extended
Experimental Procedures.
To measure mtDNA copy number, total cellular DNA was amplified using
specific oligodeoxynucleotides formt-Co2 and Sdha by real-time PCR. Details
can be found in the Extended Experimental Procedures.
Cell Biology
MEFs and human embryonic kidney 293 cells (HEK293) cells were cultured as
described (Gomes et al., 2011). When indicated, in DMEM, glucose was
substituted with 0.9 mg/ml galactose. Ecotropic viruses were generated as
described (Cheng et al., 2001). WT, Opa1flx/flx, Opa1tg, and MAFs SV40 trans-
formed cell lines were generated from the diaphragm of the respective
7-week-old mouse killed by cervical dislocation. Details on the procedure
can be found in the Extended Experimental Procedures. Acute Opa1 ablation
in Opa1flx/flx MAFs was obtained by infection with adenoviruses expressing
cytomegalovirus (CMV)-Cre-GFP (ad-CRE; 300 pfu/cell; Vector Biolabs).
CMV-GFP (ad-EV)-expressing adenoviruses were used as control.
Cell growth was determined by counting viable cells for the indicated time.
Opa1flx/flx MAFs were infected and DKO MEFs were transduced 24 or 16 hr
before the growth was assessed.
Apoptosis was measured by flow cytometric detection (FACSCalibur) of the
Annexin-V-PE positive events in the GFP-positive population. Details can be
found in the Extended Experimental Procedures.
Imaging and Transmission Electron Microscopy
For mitochondrial imaging, cells stained with a rabbit polyclonal anti-TOM20
(Santa Cruz; 1:200), as previously described (Frezza et al., 2006), were
analyzed by confocal microscopy. Adenovirus-infected cells were identified
by GFP expression. Electron microscopy (EM) was performed as described
(Scorrano et al., 2002). Details can be found in the Extended Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
six figures and can be found with this article online at http://dx.doi.org/10.
1016/j.cell.2013.08.032.
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Summary  
Mitochondrial morphological changes have been implied in apoptosis and 
autophagy in several in vitro models, but their relevance to tissue adaptation to 
damaging insults is unexplored. Here we show that controlled mild 
overexpression of Optic atrophy 1 (OPA1), an inner mitochondrial membrane 
protein that controls cristae remodeling and mitochondrial respiratory efficiency, 
protects multiple tissues from apoptotic, necrotic and atrophic stimuli. Targeted 
insertion of one copy of OPA1 in a permissive X chromosome locus does not 
interfere with mouse development, but it protects from ischemic damage in the 
heart and the brain, as well as from muscular atrophy and hepatocellular 
apoptosis. Mechanistically, OPA1 stabilizes the cristae, increasing mitochondrial 
respiratory efficiency, blunting cytochrome c release in vitro and in vivo as well 
as mitochondrial dysfunction. Our results indicate that the OPA1-dependent 
cristae remodeling pathway is an essential determinant of the cellular response 
to tissue damage in vivo.  
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Introduction 
Mitochondria are crucial organelles mediating several key processes such as 
energy conversion and calcium homeostasis (Danial et al., 2003; Rizzuto et al., 
2000). Impaired mitochondrial function is involved in cellular damage especially in 
tissues with high energy demand such as heart, skeletal muscle, and nervous 
system (DiMauro and Schon, 2003). Cellular damage is not only the consequence 
of the bioenergetic failure of mitochondria, since these organelles play also a 
crucial role in apoptosis. They integrate and release lethal signals leading to cell 
death (Green and Kroemer, 2004). In response to several stimuli mitochondria 
release cytochrome c and other pro-apoptotic proteins that execute the demise of 
the cell (Wang, 2001). Mitochondrial permeabilization during apoptosis is 
controlled by members of the Bcl-2 family and is accompanied by both 
morphological and ultrastructural changes of the organelle (Danial and Korsmeyer, 
2004; Wasilewski and Scorrano, 2009). Mitochondrial network fragmentation and 
cristae remodeling with the widening of the cristae junction are both required for 
the complete release of cytochrome c (Scorrano et al., 2002; Yamaguchi et al., 
2008).  
Mitochondria are highly dynamic organelles that continuously fuse and divide. 
These processes are controlled by a family of Dynamin-related large GTPases 
(Griparic and van der Bliek, 2001). Mitochondrial fission is regulated by the 
recruitment of Dynamin related protein (DRP) 1 on the outer mitochondrial 
membrane (OMM) upon calcineurin dependent dephosphorylation (Cereghetti et 
al., 2008), where it binds to its adaptors on the OMM like fission 1 (Fis1), 
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mitochondrial fission factor (MFF) and mitochondrial division (Mid) 49 and 51 
(Palmer et al., 2011). This fission process is counterbalanced by mitochondrial 
fusion, controlled  by Mitofusins (MFN) 1 and 2, in the OMM, and by OPA1 in the 
inner mitochondrial membrane (IMM) (Chen et al., 2003; Santel et al., 2003; 
Cipolat et al., 2004). The IMM is the metabolically active site of the organelle and it 
can be divided in two subcompartments, the so-called “boundary membrane” and 
the cristae, separated from the former by narrow tubular junctions (Frey and 
Mannella, 2000). Cristae shape is not static, as it became apparent when the 
transition from the orthodox to the condensed morphology upon activation of 
mitochondrial respiration was discovered (Hackenbrock, 1966). A different 
modification occurs during apoptosis, when cristae membrane curvature is 
inverted and the tubular cristae junctions enlarge in a process that is required for 
the complete release of cytochrome c (Scorrano et al., 2002). Remodeling of 
mitochondrial cristae occurs in response to pro-apoptotic BH3-only BCL-2 family 
members such as BID, BIM-S and BNIP3 and independently of outer membrane 
permeabilization (Scorrano et al., 2002; Yamaguchi et al., 2008; Landes et al., 
2010). In addition and independently to its role in mitochondrial fusion, OPA1 
regulates mitochondrial apoptotic cristae remodeling (Frezza et al., 2006; Cipolat 
et al., 2006). OPA1 form oligomers that participate in formation and maintenance 
of cristae junctions. During apoptosis these complexes are disrupted leading to 
widening of cristae junctions and subsequent redistribution of cytochrome c 
(Frezza et al., 2006). Moreover, OPA1 has a direct metabolic effect, stabilizing 
79 
 
respiratory chain supercomplexes (RCS) by maintaining mitochondrial cristae 
morphology (Cogliati et al., 2013).  
Cristae remodeling does not occur after the permeabilization of the outer 
membrane, but it appears to represent a subroutine engaged early in response to 
an apoptotic insult to mitochondria and not a part of a late amplificatory loop 
(Frezza et al., 2006; Yamaguchi et al., 2008; Cogliati et al., 2013). An elegant 
correlative light-electron tomography study reported instead that a caspase 
inhibitor blocked cristae remodeling but not the release of cytochrome c, albeit 
possible experimental artifacts associated with the use of a cytochrome c-4CYS 
reporter molecule, which in principle does not behave like the endogenous 
cytochrome c pool and requires harsh treatment to the cells in order to be 
visualized (Sun et al., 2007; Goldstein et al., 2005) could confound the conclusions 
of this report. Moreover, cristae remodeling has been so far described at best in 
cells and our understanding of its role in reversible and irreversible cell damage in 
vivo is at best scant. The identification of the key role of OPA1 in cristae 
remodeling suggests a potential approach to manipulate this process in the living 
animal; however, constitutive as well as conditional tissue specific OPA1 ablation is 
lethal (Zhang et al., 2011; Davies et al., 2007), while uncontrolled OPA1 
overexpression is toxic (Cipolat et al., 2004), complicating the generation of 
suitable in vivo models.  
To circumvent the difficulties related to in vivo models of cristae shape alteration, 
we recently generated a mouse model where a transgene in which expression of 
OPA1 isoform 1 under the control of the ubiquitous promoter human beta-actin 
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was purposely targeted to a permissive region of the X chromosome, without 
altering endogenous gene expression (Cogliati et al., 2013). We capitalized on this 
novel mouse model to investigate whether increased OPA1 levels that prevent 
cristae remodeling,  changes the response to tissue damage in organs with high 
metabolic activity. Our data indicate that mild OPA1 overexpression is compatible 
with life, yet it ameliorates the tissue response to apoptotic, necrotic and atrophic 
stimuli. Mechanistically, OPA1 blunts cytochrome c release and mitochondrial 
dysfunction, highlighting the importance of cristae shape in the control of cell 
death in the adult animal.   
 
Controlled OPA1 overexpression is compatible with embryonic development and 
does not affect lifespan.  
OPA1 overexpressing mice were generated by targeting a single copy of murine 
Opa1 isoform 1 driven by human β actin promoter immediately upstream of the 
Hprt locus, located in the X chromosome in the mouse (Cogliati et al., 2013) see 
also the general scheme of the targeted transgenesis strategy and the PCR analysis 
of genomic DNA in Figure 1 A, B. We chose to use the human β- actin promoter 
because  when it is close to the Hprt locus, it directs moderate expression in a wide 
variety of tissues (Bronson et al., 1996), thereby avoiding the toxic side effects 
caused by very high levels of OPA1 overexpression (Cipolat et al., 2004). Opa1tg 
mice were backcrossed for more than 10 generations in the genetic backgrounds 
C57/Bl6J and SV129. Opa1tg mice were born at the expected Mendelian frequency, 
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developed and grew normally. The resulting Opa1tg mice apparently 
indistinguishable from sex- and age-matched control wild type (Wt). A mild OPA1 
overexpression, ~1,5 was detected by western blot analysis in different tissues like 
heart, muscle, liver, brain and cerebellum (Figure 1 C, D), without concomitant 
changes in the protein expression levels of the key  proteins involved in fusion, 
fission, as well as in the pro-apoptotic and anti-apoptotic mitochondrial proteins 
(Figure 1S A, B).  There were no differences in the body weight of the Opa1tg 
compared with Wt littermates during the initial 60 days after birth. (Figure 1S C). 
However 5 months old males and females Opa1tg mice bred in the C57/Bl6J 
background showed a slightly but significant reduction in body weight compared 
to their Wt littermate, which was maintained up to 9 months of age (Figure 1 E), 
without altering however the overall survival as shown by a Kaplan-Meyer 
censorial analysis (Figure 1 F, G). Conversely, OPA1 overexpression had no effect 
on body weight in the Sv129 background  (Figure 1S D), where however it 
correlated with an increased incidence of hematological and solid tumors that 
significantly reduced lifespan (not shown). In conclusion Opa1tg mice are viable 
and display no apparent major phenotype, indicating that a mild OPA1 
overexpression is compatible with life and fertility. 
 
OPA1 protects from age-associated atrophy 
Opa1tg animals appeared in a better general health condition than their Wt 
littermates, especially when aged above 6 months. To substantiate objectively this 
subjective observation, we analyzed morphologically and histologically several 
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organs. 9 months after birth, hearts of Opa1tg mice appeared significantly bigger 
than their Wt littermates (Figure 2 A). This increase in heart size was supported by 
an increase in the heart weight / body weight ratio  that was not apparent in 
younger animals (Figure 2 B) and by a significant increase in cardiomyocyte cross-
sectional area at 9 months (Figure 2C,D), which again was not observed at 5 
months (Figure 2S A, B). However, this apparent hypertrophic phenotype was not 
accompanied by echocardiographic signs of cardiac dysfunction at 9 (Figure 2 E, F) 
or 5 months (Figure 2S C). In accordance with the functional analysis, signs of 
hypertrophy were not retrieved in 9 months old Opa1tg heart histology: (Figure 2 
G) staining for the fetal genes associated with cardiac hypertrophy (Du, 2007) such 
as beta myosin heavy chain (-MHC) (Figure H) and atrial natriuretic peptide (ANP) 
(Figure 2 I) was negative and no signs of interstitial fibrosis were detected (Figure 
2S E), exactly as in 5 month old mice (Figure 2S D). Other organs, such as liver and 
kidney were not enlarged both at the ecographic and the histological inspection 
(Figure 2S F, G, H, I). Thus, old Opa1tg mice display a non-pathological cardiac 
hypertrophy.  
 
Opa1tg mice are protected from muscular atrophy 
We reasoned that the benign heart hypertrophy observed in old Opa1tg mice could 
be explained if Opa1tg muscular cells were less susceptible to the atrophic 
program, which requires changes in mitochondrial morphology (Romanello et al., 
2010) and is exacerbated during aging when the atrophy accompanied by 
lipofuscinosis occurs (De Meyer et al., 2010).  We therefore investigated if the 
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program of muscle atrophy was altered in Opa1tg animals, by using the well-
established model of ischiotomy (Sandri et al., 2006; Adhihetty et al., 2007). 
Histological analysis did not reveal signs of inflammation, degeneration or 
regeneration in gastrocnemius sections from control or 10 days denervated 5 
months-old Wt and Opa1tg mice (Figure 3 A). However, the loss muscular mass 
after denervation was significantly less in Opa1tg mice, with a ~50% reduction in 
muscle atrophy (Figure 3B).  This protection was not explained by differences in 
the expression of mitochondrial genes involved in fission and biogenesis, or in 
atrophy and autophagy related genes before as well as after denervation, as 
measured by real-time PCR (not shown). Conversely, succinate dehydrogenase 
(SDH) staining increased in Opa1tg muscles (Figure 3 C), suggesting that 
mitochondria were untouched in the denervated Opa1tg fibers. Since autophagy 
preferentially targets dysfunctional mitochondria (Narendra and Youle, 2011) and 
during muscle atrophy dysfunctional mitochondria that lost their membrane 
potential (Seo et al., 2010) accumulate, we turned to an established assay to unveil 
the latent mitochondrial dysfunction (Irwin et al., 2003)  When we followed in real 
time the changes in the mitochondrial fluorescence of the potentiometric probe 
tetramethyl rhodamine methylester (TMRM) caused by the ATPase inhibitor 
oligomycin, we observed that in fibers isolated from denervated Wt muscles the 
ATPase inhibitor caused a paradoxical depolarization (as opposed to the expected 
hyperpolarization observed in healthy fibers where the ATPase consumes the 
electrochemical gradient to generate ATP), indicative of latent organellar 
dysfunction. In fibers from Opa1tg mice conversely the recordings before or after 
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denervation were completely superimposable (Figure 3 D), suggesting that the 
mild OPA1 overexpression protects from denervation-induced mitochondrial 
dysfunction.  Thus, OPA1 overexpression protects from atrophy by blocking 
mitochondrial dysfunction and clearance, without altering the autophagic program 
or inducing mitochondrial biogenesis. 
 
Opa1tg mice are protected from ischemic damage. 
The mitochondria-specific protection from muscular atrophy provided by OPA1 
overexpression prompted us to move to other models of tissue damage where 
mitochondria play a central role.  Myocardial infarction, besides being the leading 
cause of death in the western world, encompasses profiles of central necrosis and 
of peripheral apoptosis, where mitochondrial dysfunction participates in the 
ischemic as well as in the reperfusion phase (Murphy and Steenbergen, 2008) By 
using a classical Langendorff perfused heart preparation,  we subjected hearts of 5 
month old mice to 40 minutes of ischemia followed by 15 minutes of reperfusion 
(Barbato et al., 1996) and we  assessed cardiac injury by measuring lactate 
dehydrogenase (LDH) release during the reperfusion period. OPA1 overexpression 
drastically reduced the amount of released LDH in both C57/Bl6 (Figure 4 B) and 
SV129 (Figure 4C) as well as in male and female mice, thereby excluding potential 
confounding effects of animal genetic background and gender that influence the 
response to heart ischemia (Du, 2004). The protection was not confined to heart, 
since infarct volume , assessed in triphenyl tetrazolium chloride (TTC) stained serial 
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sections from brains three days after middle cerebral artery (MCAo) occlusion 
(Colak et al., 2011) was significantly reduced in Opa1tg mice (Figure 4 D, E, F).  
These results indicate that mild OPA1 overexpression protects heart and brain 
from ischemic damage. 
 
Opa1 tg are less susceptible to Fas-induced liver damage 
The protection afforded by OPA1 from heart and brain ischemia corroborates early 
findings that implicated OPA1 and the OPA1-dependent cristae remodeling in cell 
death. However, we wished to test this model further by turning to a model of in 
vivo apoptosis. Fas receptor activation in the liver by means of tail vein injection of 
anti-Fas activating antibodies is a well characterized model of severe apoptotic 
liver damage (Ogasawara et al., 1993) where Fas-induced death is dependent on 
mitochondria (Yin et al., 1999; Wei et al., 2000). While liver histology was not 
different in 3 months old BL6 Wt and Opa1tg mice, 24 hours after tail vain injection 
of an activating anti-Fas antibody (JO2), damage was greatly decreased in Opa1tg 
livers, where the lobular architecture was preserved and the hemorrhagic 
infiltrates where reduced (Figure 5A). Accordingly, TUNEL staining revealed a 
significant reduction in apoptotic cell death in Opa1tg livers (Figure 5 B, C). 
Mechanistically, the protection correlates with the inhibition of cytochrome c 
release from mitochondria, as revealed by the analysis of subcellular cytochrome c 
distribution in Fas-treated Wt and Opa1tg livers (Figure 5 D). Consistently, plasma 
levels of alanine and aspartate transaminases (ALT and AST), an indicator of liver 
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damage, were significantly reduced in blood samples from Fas-treated Opa1tg mice 
compared to those from their Wt treated littermates (Figure 5 E, F). Thus, OPA1 
overexpression inhibits mitochondrial dependent apoptosis in vivo.  
 
Opa1tg mitochondria are resistant to cristae remodeling and cytochrome c 
release 
We next wished to address mechanistically how OPA1 overexpression protected 
from multiple and different death stimuli in vivo. In principle, OPA1 levels 
modulate mitochondrial fusion as well as cristae shape, by inhibiting the cristae 
remodeling pathway. Moreover, they control cristae tightness, respiratory chain 
supercomplexes assembly and hence the efficiency of mitochondrial respiration. 
Indeed,  these morphological and metabolic changes were observed in 
immortalized MAFs prepared from diaphragms of Opa1tg mice (Cogliati et al., 
2013). We recapitulated the findings of slight mitochondrial elongation in primary 
myoblasts prepared from Opa1tg diaphragms (Figure 6 A ), and of tighter cristae in 
Opa1tg hearts (Figure 6 B ) as well as in other organs (not shown). Functionally, 
complex IV dependent respiration (Figure 3S A ), calcium retention capacity (CRC), 
a sensitive indicator of the threshold for mitochondrial permeability transition that 
participates in cytochrome c release (Basso et al., 2005), cyclosporine A (CsA) 
sensitivity of CRC (Figure 3S B, C), as well as mitochondrial membrane potential 
(Figure 3S D) were superimposable in Wt and Opa1tg purified mitochondria. 
However, when we turned to an established assay of cytochrome c release from 
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purified liver mitochondria treated with recombinant cleaved, active BID (cBID), 
(Scorrano et al., 2002; Frezza et al., 2006), we observed that Opa1tg mitochondria 
were releasing less cytochrome c (Figure 6 C), despite that cBID caused the same 
extent of BAK activation (measured as its oligomerization) in wt and Opa1tg 
mitochondria (Figure 3S E).We therefore turned to an established assay of 
cytochrome c mobilization from the cristae, measuring the ratio of ascorbate (asc) 
driven over tetramethy-p-phenyenediamine (TMPD) driven respiration   (Scorrano 
et al., 2002). While  basal asc/TMPD ratio was not affected in Opa1tg mitochondria, 
the increase in the ratio caused by cBID was completely blocked in Opa1tg 
mitochondria (Figure 6 D), indicating that the apoptotic redistribution of 
cytochrome c was blocked in Opa1tg mitochondria. Accordingly, the OPA1 
oligomers targeted by cBID to trigger cristae remodeling and cytochrome c 
redistribution were stabilized in in Opa1tg mitochondria  (Figure 6 E, F). Taken 
together these results indicate that a mild OPA1 overexpression is sufficient to 
protect from apoptotic cristae remodeling in vivo. 
 
Discussion 
The field of mitochondrial dynamics exploded when the processes of cristae 
remodeling and mitochondrial fragmentation during apoptosis were discovered 
(Scorrano et al., 2002; Frank et al., 2001; Martinou et al., 1999). The discovery that 
OPA1 controls cristae remodeling (Frezza et al., 2006) and RCS assembly and 
stability (Cogliati et al., 2013) offered a conceptual framework to explore whether 
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OPA1 overexpression interfered with cell death in vivo. Our results indicate that 
mild OPA1 overexpression is compatible with life and protects animals from 
multiple form of death, implicating cristae remodeling in myocardial and brain 
infarction, hepatocellular apoptosis and muscular atrophy.  
Our strategy to investigate the role of cristae remodeling in vivo has been to 
modulate the levels of its master regulator OPA1. Not surprisingly, given the 
crucial role of this protein in mitochondrial physiology, its ablation is lethal early 
during intrauterine development (Davies et al., 2007) and its inducible deletion in 
differentiated tissues such as brain and skeletal muscle is similarly fatal (not 
shown). We therefore turned to a different approach and generated a mouse 
model of targeted, controlled OPA1 overexpression (Cogliati et al., 2013) where 
we could avoid the paradoxical toxic effects of high OPA1 expression (Cipolat et al., 
2004). 
OPA1 overexpression does not impair fertility, intrauterine development, adult life 
and even lifespan, a surprising lack of effect for a gene with a potential 
antiapoptotic effect. It shall be mentioned however that in the more permissive 
SV129 background the incidence of spontaneous cancer is significantly increased 
and lifespan is accordingly reduced. The overexpression of the bona fide apoptosis 
inhibitors Bcl-2 and Bcl-Xl is even less potent in promoting cancer per se (except 
for the expression restricted in the B cell compartment, (Frenzel et al., 2009)): for 
example, a BCl-Xl skin transgene did not show increased incidence of skin cancer 
or precancerous lesions (Pena et al., 1998). Moreover, mitochondrial apoptosis is 
required for the normal development (Wang, 2001) and OPA1 does not interfere 
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with the core apoptotic machinery of outer membrane permeabilization (here and 
(Frezza et al., 2006). Therefore, the finding of spontaneous cancer development 
remains to be accurately investigated from the molecular point of view.  
The observation of non-pathological heart hypertrophy in Opa1tg mice prompted 
us to verify if this trasngene had any effect on muscular atrophy. Chronic muscle 
disuse induced by denervation results in mitochondrial alterations and muscle 
atrophy (Adhihetty et al., 2007) Interestingly, disruption of the mitochondrial 
network is an essential loop of this muscular atrophy program (Romanello et al., 
2010). The preservation of heart size during aging perfectly correlated with the 
anti-atrophic effect of OPA1 overexpression in the skeletal muscle: remarkably, 
while OPA1 overexpression did not impinge on mitochondrial biogenesis or 
autophagy, it sustained mitochondrial function and prevented their elimination. 
OPA1 expression indeed triggered a slight mitochondrial elongation, which was 
accompanied by a remarkable increase in respiratory capacity that correlated with 
the cristae tightness (Cogliati et al., 2013). Thus, amelioration of mitochondrial 
cristae seems a feasible strategy to counteract muscular atrophy, an emerging 
medical problem in the aging society. 
In addition to skeletal muscle, brain and heart are also high energy demanding 
tissues where mitochondrial dysfunction is invariably detrimental. Indeed, 
ischemia and ischemia/reperfusion injury are associated with a dramatic change in 
mitochondrial morphology and ultrastructure (Calo et al., 2013). We observed that 
mild OPA1 overexepression was sufficient to improve enzymatic parameters 
associated with tissue damage in response to ischemic injury. In addition to its role 
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in apoptosis, mitochondrial dynamics has been recently implied in necrosis and 
necroptosis (Orogo and Gustafsson, 2013) (Wang et al., 2012). Our results suggest 
that cristae remodeling is central also to propagate the necrotic damage and that 
its prevention can ameliorate the ischemic damage outcome. Notably, OPA1 
overexpression did not increase brain or heart vascularization, suggesting a direct 
effect on the mechanisms of ischemic cell damage. 
One of the best characterized in vivo apoptotic pathways is that induced by the 
activation of Fas-R. The liver, where Fas is constitutively expressed on hepatocytes 
(Ogasawara et al., 1993) is not surprisingly very sensitive to Fas-mediated 
apoptosis.. Because hepatocytes are type II cells in which Fas-induced death is 
dependent on mitochondrial pathway, the model of liver apoptosis by Fas-R 
activation has been widely employed to study apoptosis in vivo (Rodriguez et al., 
1996; Yin et al., 1999; Wei et al., 2001). In addition to muscular atrophy and 
ischemia/reperfusion, OPA1 overexpression also protected from hepatocellular 
apoptosis. The mechanistic analysis allowed to conclude that OPA1 expression 
does not interfere with Bax, Bak mediated outer membrane permeabilization, yet 
it protects from cytochrome c release in vitro and in vivo by counteracting the 
intramitochondrial redistribution that accompanies cristae remodeling. Our work 
unravels a role for cristae shape in multiple forms of cell death in vivo.  The use of 
a mouse model of mild, controlled OPA1 overexpression allowed us to test the 
hypothesis that OPA1 and cristae remodeling modulate apoptosis. The analysis of 
this OPA1 overexpressing mouse extended the forms of death controlled by 
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mitochondrial remodeling and indicated a crucial role for mitochondrial 
ultrastructure in tissue adaptation to pathological stimuli.   
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Experimental procedures 
In vivo experiments 
Generation of OPA1 overexpressing mice 
Experimental procedures for the generation of Opa1tg mice was described in 
(Cogliati et al., 2013). Opa1tg mice were initially developed in a mixed genetic 
background of C57BL/6 x Sv/129  and were backcrossed to C57BL/6 and SV/129 for 
more than 10 generations. The genotype is determined by analysis of DNA 
extracted from tail biopsy, via  Polymerase Chain Reaction (PCR).  
 
Echocardiography.  
Echocardiography was performed in adult (5 and 9 month) Opa1tg (n=6) and age- 
and sex-matched littermate controls (n=6), using a Vevo 2100™ (Visual Sonics, 
Toronto, Canada) system equipped with a 30 MHz transducer. Anesthesia was 
induced with 3% isoflurane, maintained with 1.5% isoflurane during constant 
monitoring of temperature, respiration rate, and ECG. Two-dimensional cine loops 
with frame rates of 200 frames/s of a long-axis view and a short-axis view at 
proximal-, mid- and apical level of the left ventricle (LV) were recorded. Inter 
ventricular septum (IVS) and LV posterior wall (LVPW) thicknesses, LV internal 
diameter (LVID) and maximal LV length were measured in systole (s) and in 
diastole (d) from the long axis B-mode image, according to standard procedures. 
Ejection fraction (EF) was determined by the following formula: Simp EF (%) = 100 
x  Simp Systolic Volume (SV)/ Simp LV volume; d. To assess changes in LV shape, 
the sphericity index (SI) was calculated at end-diastole (d) and end-systole (s) as 
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the volume of the LV divided by the volume of a sphere with a diameter equal to 
the LV longest axis (measured in the apical view) using the following formulas: SI: d 
= LV volume; d/(3/4*Π*( Simp Length; d)3); SI: s = LV volume; s/(3/4*Π*( Simp 
Length; s)3). As this ratio increases, the ventricle becomes more spherical. 
Echocardiographic image acquisition and analysis were performed by a single 
operator, blinded to the mouse genotype. 
 
Muscle denervation 
Denervation was performed by cutting sciatic nerve of the left hind limb, the right 
hind limb was used as control. 5 months old males were used. 10 days after 
denervation animals were killed by cervical dislocation and muscles were utilized 
for histological experiments or gene expression  studies. 
 
Heart Ischemia and Reperfusion 
Heart Ischemia and Reperfusion was performed according to Langendorff 
experimental  model. The hearts were removed from cervical dislocated 5 months 
sex matched animals and treated as follows : after 10 min of stabilization, 
experimental hearts were subjected to 40 min of global ischemia  by stopping the 
coronary flow and 15 min of reperfusion. The hearts were perfused with 
bicarbonate buffer gassed with 95% O2-5% CO2 at 37 °C (pH 7.4) at a constant flux 
of 5 ml/min. Perfusion was performed in the nonrecirculating Langendorff model, 
as previously described (Barbato et al., 1996) The bicarbonate buffer contained (in 
mM) 118.5 NaCl, 3.1 KCl, 1.18 KH2PO4, 25.0 NaHCO3, 1.2 MgCl2, 1.4 CaCl2 and 
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5.6  glucose. Lactate dehydrogenase (LDH) accumulated in the coronary effluent 
during reperfusion period was collected for the quantification of myocardial cell 
damage. After reperfusion the hearts were quickly immersed into PBS 
supplemented with 0,5% Triton X100 and homogenized for measurement of total 
lactate dehydrogenase (LDH). 
 
Brain Ischemia  
Animals were sacrificed 3 days after Middle Cerebral Artery (MCA) occlusion. MCA 
ligation surgery in mice and 2,3,5 Triphenyltetrazolium chloride (TTC) staining for 
quantification of infarct volumes was performed exactly as described in (Colak et 
al., 2011). 
 
Tail vein injection 
Three months old mice were injected intravenously with anti-Fas antibody (Jo2 BD 
Pharmingen), at a dose of 0,25g/g.  Animals were observed and sacrificed 24 h 
after injection, for liver histology and biochemical analysis.   
 
In vitro mitochondrial assays 
Liver and muscle mitochondria from the indicated phenotype were isolated by 
standard differential centrifugation as described in (Frezza et al., 2007). 
Cytochrome c redistribution and release in response to recombinant cBID was 
determinate as described in (Scorrano et al., 2002). Mitochondrial oxygen 
consumption was measured with a Clark type oxygen electrode (Hansatech). 
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1mg/ml  mitochondria in Experimental Buffer (EB: 150 mM KCl, 10 mM Tris Mops, 
10 μM EGTA-Tris,), 5mM/2.5mM glutamate malate or 10mM succinate were 
added. Basal O2 consumption was recorded (state 2) and after 2 minutes 100 μM 
ADP was added (state 3), followed by 2.5 μg/mL oligomycin to determine state 4 
respiration, FCCP was added to asses maximal respiration. Complex IV-driven 
respiration was determined with the addition of 3 mM ascorbate plus 150 mM 
TMPD in the presence 1mg/ml  mitochondria in EB supplemented with 5 mM 
cytochrome c  
 
Mitochondrial membrane potential 
Mitochondrial membrane potential in isolated FDB (flexor digitorum brevis) 
muscle fibres was measured by intensity of TMRM fluorescence. Briefly, FDB 
myofibres were placed in 1ml Tyrode’s buffer and loaded with 5 nM TMRM 
(Molecular Probes) supplemented with 1 mM cyclosporine H (a Pglycoprotein 
inhibitor) for 30 min at 37°C. Myofibres were then observed at Olympus IX81 
inverted microscope (Melville, NY) equipped with a CellR imaging system. 
Sequential images of TMRM fluorescence were acquired every 60 s with a 4X 
objective (Olympus). At the times indicated by arrows, oligomycin (5 mM) (Sigma) 
or the uncoupler  carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP, 4 
mM) (Sigma) was added. TMRM fluorescence analysis  over mitochondrial regions 
of interest was performed using ImageJ software. 
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Biochemistry 
For protein crosslinking, mitochondria were treated as indicated with 1mM EDC or 
1 mM BMH as previously described (Frezza et al., 2006). For SDS-PAGE, equal 
amounts of mitochondrial proteins (were separated on 3%-8% Tris-acetate or 4%-
12% Tris-MES (NuPage, Invitrogen) polyacrilamide gel, transferred onto PVDF 
membranes (Biorad) and probed using the indicated primary antibodies and 
isotype matched secondary antibodies conjugated to horseradish peroxidase. 
Signal was detected with ECL (Amersham). Details on the antibodies used can be 
found in Supplemental data. Densitometry was performed 
 
BN PAGE 
To detect OPA1 oligomers, mitochondria were resuspended in an appropriated 
volume of Buffer D (1M 6-aminohexanoic acid, 1.25% V/V digitonin, 50mM Bis-
Tris-HCl, pH 7) at a final concentration of 10 mg/ml. Following centrifugation, the 
supernatant was collected and 5% Serva Blue G dye in 1M 6-aminohexanoic acid 
was added to one-third of the final volume of the sample. Equal amounts (100 μg) 
of mitochondrial proteins were separated on a 3%-12% gradient BNGE Invitrogen 
as described in (Schagger, 1995).  
 
Histology and  immunofluorescence staining. 
Heart, muscle and liver tissue from the indicated genotypes  were  fixed in 1% 
paraformaldehyde (PFA) (Sigma) at room temperature for 15 minutes, equilibrated 
in sucrose gradient, frozen in liquid nitrogen, sectioned and processed for 
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histological and immunofluorescence analyses. Livers also were, cut into small 
pieces and fixed overnight at 4°C in 4% paraformaldehyde in PBS, and then 
dehydrated through serial ethanol concentration for paraffin embedding. Paraffin 
embedded livers were used for TUNEL, haematoxylin and eosin staining. 
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Figure Legends 
Figure 1. Characterization of Opa1tg mice 
(A) Schematic representation of targeted transgenesis strategy into the permissive 
hypoxanthine phosporibosytransferese (HPRT) locus. The targeted vector include a 
5’ HPRT homology arm, -actin promoter, the transgene cDNA OPA1 isoform1  and 
3’ HPRT homology arm including a part of HPRT promoter and an homologous 
region to the mouse HPRT locus. The targeting construct is linearized before 
electroporation into BPES cells. Homologous recombination of the 3’ arm 
reconstitutes a functional HPRT gene, allowing the selection of targeted BPES cells 
on stringent hypoxanthine-aminopterin-thymidine (HAT) conditions. 
(B) PCR analysis of genomic DNA from wild-type (Wt) mice, heterozygous 
(Opa1(+/-) and homozygous (Opa1(+/+) Opa1tg mice tail.  
(C) Equal amounts of protein from tissues of the indicated genotypes were 
separated by SDS-PAGE and immunoblotted with the indicated antibodies. 
(D) Densitometric analysis of OPA1 protein level in tissue from heart and muscle. 
Data represent average + SEM (n=7 for each group); asterisk denotes p<0,05 in an 
unpaired sample Student’s test. 
(E) Body weight is represented as average + SEM of 5 months males (n= 34 for 
each group) and females (n= 13 for each group) and 9 months old males (n= 18 for 
each group) and females (n= 16 for each group) C57/Bl6 Opa1tg  and Wt 
littermates. The asterisk denotes p<0.05 in a two tailed ANOVA test.  
(F, G ) Kaplan-Meier survival curve of Wt and Opa1tg  males and females 
littermates (n=10) . 
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Figure 2. Non-pathological cardiac hypertrophy in 9 months old Opa1tg  mice 
(A) Representative images of hearts dissected from 5 months (top) and 9 months 
(bottom) old Wt and Opa1tg littermates.  
(B) Evaluation of heart weight/body weight ratio in Wt and Opa1tg mice. Data 
represent average + SEM (n=8 for each group 5 months old mice and n=4 for each 
group 9 months old mice). Asterisk indicates p<0.05 in an unpaired sample 
Student’s test versus 5 months old genotype matched dataset. 
(C) Immunofluorescence analysis on ventricular cryosections from Wt and Opa1tg  
mice stained for dystrophin. Images are details from the left ventricle. 
(D) Cardiomyocyte cross-sectional area (CSA) (pixel)  in cryosections from Wt and 
Opa1tg 9 months old mice. Data are average + SEM. (n=4 for each group). The 
asterisk denotes p<0.05 in an unpaired sample Student’s test.  
(E, F) Echocardiographic long axis view of hearts from  9 months old Wt and Opa1tg 
littermates. LV: left ventricle; A: aorta. Percentage of cardiac ejection fraction (FE) 
and shortening (FS) are represented in (F).  
(G) Haematoxilin-eosin staining of ventricular cryosections from Wt and Opa1tg  
mice.  
(H,I) Immunofluorescence analysis of ventricular cryosections from Wt and Opa1tg 
mice stained for  beta myosin heavy chain (-MHC, H) and to antrial natriuretic 
peptide (ANP) (I).  
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Figure 3.  Muscle atrophy induced by denervation is reduced in Opa1tg mice 
(A) Haematoxilin-eosin staining of control and 10 days denervated gastrocnemial 
crysections from C57/Bl6 Wt and Opa1tg  male littermates.  
(B) Quantification of muscle loss 10 days after denervation by cross-sectional area 
(CSA) measurement of innervated and denervated fibers (n=5 for each group) Data 
are average ±SEM. The asterisk denotes p<0.05 in an unpaired sample Student’s 
test.  
(C) Representative images of succinate dehydrogenase (SDH) staining in control 
and denervated garstocnemius cryosections from  Wt and Opa1tg  littermates.  
(D) Quantitative analysis of TMRM fluorescence over mitochondrial regions in 
isolated fibers from Opa1tg and Wt control and denervated FDB (flexor digitorum 
bevis) muscles. Data are average + SEM. (n=5 for each group).  
 
Figure 4.  Opa1tg mice are less susceptible to ischemic damage 
(A) Schematic representation of the Langendorff experimental model used.  
(B,C) Quantitative analysis of lactate dehydrogenase (LDH) released  during  
reperfusion in the coronary effluent in 5 months old Wt and Opa1tg  males and 
females of the indicated background (n=8 for each group). Data represent average 
±SEM. The asterisk denotes p<0.05 in a two tailed ANOVA test.  
(D) Representative images of TTC stained whole brains from 3 months old females 
Wt and Opa1tg SV129 mice 72h after middle cerebral artery occlusion (MCAo).  
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(E) Representative TTC stained 250m brain sections, 72h after MCAo. Slices are 
aligned from anterior to posterior.  
(F) Quantification of infarct volume 72h post MCAo. Data represent average ±SEM 
(n =4 for each group). The asterisk denotes p<0.05 in an unpaired sample Student’s 
test. 
 
Figure 5. Apoptotic liver damage is reduced in Opa1tg mice 
(A) Representative images of Hematoxylin-eosin stained paraffin embedded  liver 
sections from Wt and Opa1tg  mice. Mice were tail vein injected with saline 
solution (control) or with 0,25 -Fas (Jo-2) , sacrificed after 24h 
and livers explanted for histology.  
(B) TUNEL staining of paraffin embedded liver sections from Wt and Opa1tg control 
and 24h following anti -Fas injection. Arrows represent TUNEL positive 
hepatocytes.  
(C) Quantification of TUNEL positive hepatocyte per field in experiments as in (B). 
Data represent average ± SEM of four independent experiments (at least 30 
images per group per experiment).  
(D) Double-color immunohistochemistry of liver cryosections  from control or anti-
Fas injected Wt and Opa1tg mice. Cytochrome c staining is in green, Tom 20 in red.  
(E) Plasma ALT levels of the indicated genotypes at the indicated time point. Data 
represent average ±SEM (n=7 for each group). The asterisk denotes p<0,05 in an 
unpaired ANOVA tests.  
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(F) Plasma AST levels of the indicated genotypes at the indicated time point. Data 
represent average ±SEM (n=8 for each group). The asterisk denotes p<0.05 in an 
unpaired ANOVA test 
 
Figure 6. Cytochrome c release is reduced from Opa1tg mitochondria 
(A) Representative images of mitochondrial network of primary myoblast from Wt 
and Opa1tg after transfection with mito-YFP.  
(B) Electron micrographs of heart mitochondria of the indicated genotype.  
(C) Mitochondria isolated from livers of the indicated genotypes were treated for 
the indicated times with 40pmol/mg cBID and cytochrome c release was  
measured. Data represent average ±SEM of 5 independent experiments.  
(D)  Ascorbate/TMPD –driven respiration of Wt and Opa1tg liver mitochondria  
treated where indicated for  15 min with cBID. Data represent average ±SEM of 4 
independent experiments. The asterisk denotes p<0.05 in an unpaired Student’s 
test.  
(E) Muscle mitochondria were treated with cBID and  10 mM EDC was added at the 
indicated time. Mitochondrial proteins (30 g) were analyzed by SDS-
PAGE/Immunoblotting using anti-OPA1 antibody.  
(H) BNGE analysis of OPA1 oligomers in muscle mitochondria of the indicated 
genotypes treated for the indicated times  with cBID. 
 
 
 
104 
 
 
Figure 1 
 
105 
 
Figure 2 
 
106 
 
 
 
Figure 3 
107 
 
 
 
 
Figure 4 
 
 
 
 
108 
 
Figure 5 
 
109 
 
Figure 6 
 
110 
 
Reference List 
 
Adhihetty,P.J., O'Leary,M.F.N., Chabi,B., Wicks,K.L., and Hood,D.A. (2007). Effect of denervation 
on mitochondrially mediated apoptosis in skeletal muscle. Journal of Applied Physiology 102, 
1143-1151. 
Barbato,R., Menabo,R., Dainese,P., Carafoli,E., Schiaffino,S., and DiLisa,F. (1996). Binding of 
cytosolic proteins to myofibrils in ischemic rat hearts. Circulation Research 78, 821-828. 
Basso,E., Fante,L., Fowlkes,J., Petronilli,V., Forte,M.A., and Bernardi,P. (2005). Properties of the 
permeability transition pore in mitochondria devoid of Cyclophilin D. J. Biol. Chem. 280, 18558-
18561. 
Bronson,S.K., Plaehn,E.G., Kluckman,K.D., Hagaman,J.R., Maeda,N., and Smithies,O. (1996). 
Single-copy transgenic mice with chosen-site integration. Proceedings of the National Academy 
of Sciences of the United States of America 93, 9067-9072. 
Calo,L., Dong,Y., Kumar,R., Przyklenk,K., and Sanderson,T.H. (2013). Mitochondrial Dynamics: An 
Emerging Paradigm in Ischemia-Reperfusion Injury. Current Pharmaceutical Design 19, 6848-
6857. 
Cereghetti,G.M., Stangherlin,A., Martins de,B.O., Chang,C.R., Blackstone,C., Bernardi,P., and 
Scorrano,L. (2008). Dephosphorylation by calcineurin regulates translocation of Drp1 to 
mitochondria. Proc. Natl. Acad. Sci. U. S. A 105, 15803-15808. 
Chen,H., Detmer,S.A., Ewald,A.J., Griffin,E.E., Fraser,S.E., and Chan,D.C. (2003). Mitofusins Mfn1 
and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic 
development. J. Cell Biol. 160, 189-200. 
Cipolat,S., de Brito,O.M., Dal Zilio,B., and Scorrano,L. (2004). OPA1 requires mitofusin 1 to 
promote mitochondrial fusion. Proc. Natl. Acad. Sci. U. S. A 101, 15927-15932. 
Cipolat,S., Rudka,T., Hartmann,D., Costa,V., Serneels,L., Craessaerts,K., Metzger,K., Frezza,C., 
Annaert,W., D'Adamio,L., Derks,C., Dejaegere,T., Pellegrini,L., D'Hooge,R., Scorrano,L., and De 
Strooper,B. (2006). Mitochondrial Rhomboid PARL Regulates Cytochrome c Release during 
Apoptosis via OPA1-Dependent Cristae Remodeling. Cell 126, 163-175. 
Cogliati,S., Frezza,C., Soriano,M.E., Varanita,T., Quintana-Cabrera,R., Corrado,M., Cipolat,S., 
Costa,V., Casarin,A., Gomes,L.C., Perales-Clemente,E., Salviati,L., Fernandez-Silva,P., 
Enriquez,J.A., and Scorrano,L. (2013). Mitochondrial Cristae Shape Determines Respiratory Chain 
Supercomplexes Assembly and Respiratory Efficiency. Cell 155, 160-171. 
Colak,G., Filiano,A.J., and Johnson,G.V. (2011). The application of permanent middle cerebral 
artery ligation in the mouse. J. Vis. Exp. 
Danial,N.N., Gramm,C.F., Scorrano,L., Zhang,C.Y., Krauss,S., Ranger,A.M., Datta,S.R., 
Greenberg,M.E., Licklider,L.J., Lowell,B.B., Gygi,S.P., and Korsmeyer,S.J. (2003). BAD and 
glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis. Nature 
424, 952-956. 
Danial,N.N. and Korsmeyer,S.J. (2004). Cell death: critical control points. Cell 116, 205-219. 
Davies,V.J., Hollins,A.J., Piechota,M.J., Yip,W., Davies,J.R., White,K.E., Nicols,P.P., Boulton,M.E., 
and Votruba,M. (2007). Opa1 deficiency in a mouse model of autosomal dominant optic atrophy 
111 
 
impairs mitochondrial morphology, optic nerve structure and visual function. Hum. Mol. Genet. 
16, 1307-1318. 
De Meyer,G.R.Y., De Keulenaer,G.W., and Martinet,W. (2010). Role of autophagy in heart failure 
associated with aging. Heart Failure Reviews 15, 423-430. 
DiMauro,S. and Schon,E.A. (2003). Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 348, 
2656-2668. 
Du,X.J. (2004). Gender modulates cardiac phenotype development in genetically modified mice. 
Cardiovascular Research 63, 510-519. 
Du,X.J. (2007). Divergence of hypertrophic growth and fetal gene profile: the influence of beta-
blockers. British Journal of Pharmacology 152, 169-171. 
Frank,S., Gaume,B., Bergmann-Leitner,E.S., Leitner,W.W., Robert,E.G., Catez,F., Smith,C.L., and 
Youle,R.J. (2001). The role of dynamin-related protein 1, a mediator of mitochondrial fission, in 
apoptosis. Dev. Cell 1, 515-525. 
Frenzel,A., Grespi,F., Chmelewskij,W., and Villunger,A. (2009). Bcl2 family proteins in 
carcinogenesis and the treatment of cancer. Apoptosis 14, 584-596. 
Frey,T.G. and Mannella,C.A. (2000). The internal structure of mitochondria. Trends. Biochem. Sci. 
25, 319-324. 
Frezza,C., Cipolat,S., Martins,d.B., Micaroni,M., Beznoussenko,G.V., Rudka,T., Bartoli,D., 
Polishuck,R.S., Danial,N.N., De Strooper,B., and Scorrano,L. (2006). OPA1 Controls Apoptotic 
Cristae Remodeling Independently from Mitochondrial Fusion. Cell 126, 177-189. 
Frezza,C., Cipolat,S., and Scorrano,L. (2007). Organelle isolation: functional mitochondria from 
mouse liver, muscle and cultured fibroblasts. Nat. Protoc. 2, 287-295. 
Goldstein,J.C., Munoz-Pinedo,C., Ricci,J.E., Adams,S.R., Kelekar,A., Schuler,M., Tsien,R.Y., and 
Green,D.R. (2005). Cytochrome c is released in a single step during apoptosis. Cell Death. Differ. 
12, 453-462. 
Green,D.R. and Kroemer,G. (2004). The pathophysiology of mitochondrial cell death. Science 305, 
626-629. 
Griparic,L. and van der Bliek,A.M. (2001). The many shapes of mitochondrial membranes. Traffic 
2, 235-244. 
Hackenbrock,C.R. (1966). Ultrastructural bases for metabolically linked mechanical activity in 
mitochondria. I. Reversible ultrastructural changes with change in metabolic steady state in 
isolated liver mitochondria. J. Cell Biol. 30, 269-297. 
Irwin,W.A., Bergamin,N., Sabatelli,P., Reggiani,C., Megighian,A., Merlini,L., Braghetta,P., 
Columbaro,M., Volpin,D., Bressan,G.M., Bernardi,P., and Bonaldo,P. (2003). Mitochondrial 
dysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nature Genetics 35, 
367-371. 
Landes,T., Emorine,L.J., Courilleau,D., Rojo,M., Belenguer,P., and rnaune-Pelloquin,L. (2010). The 
BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and 
apoptosis by distinct mechanisms. EMBO Rep. 11, 459-465. 
112 
 
Martinou,I., Desagher,S., Eskes,R., Antonsson,B., Andre,E., Fakan,S., and Martinou,J.C. (1999). 
The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic 
neurons is a reversible event. J. Cell Biol. 144, 883-889. 
Murphy,E. and Steenbergen,C. (2008). Mechanisms underlying acute protection from cardiac 
ischemia-reperfusion injury. Physiological Reviews 88, 581-609. 
Narendra,D.P. and Youle,R.J. (2011). Targeting Mitochondrial Dysfunction: Role for PINK1 and 
Parkin in Mitochondrial Quality Control. Antioxidants & Redox Signaling 14, 1929-1938. 
Ogasawara,J., Watanabefukunaga,R., Adachi,M., Matsuzawa,A., Kasugai,T., Kitamura,Y., Itoh,N., 
Suda,T., and Nagata,S. (1993). Lethal Effect of the Anti-Fas Antibody in Mice. Nature 364, 806-
809. 
Orogo,A.M. and Gustafsson,A.B. (2013). Cell death in the myocardium: My heart won't go on. 
Iubmb Life 65, 651-656. 
Palmer,C.S., Osellame,L.D., Laine,D., Koutsopoulos,O.S., Frazier,A.E., and Ryan,M.T. (2011). 
MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Rep. 12, 565-
573. 
Pena,J.C., Rudin,C.M., and Thompson,C.B. (1998). A Bcl-xL transgene promotes malignant 
conversion of chemically initiated skin papillomas. Cancer Res. 58, 2111-2116. 
Rizzuto,R., Bernardi,P., and Pozzan,T. (2000). Mitochondria as all-round players of the calcium 
game. Journal of Physiology-London 529, 37-47. 
Rodriguez,I., Matsuura,K., Khatib,K., Reed,J.C., Nagata,S., and Vassalli,P. (1996). A bcl-2 
transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from 
rapid death induced by anti-Fas antibody injection. Journal of Experimental Medicine 183, 1031-
1036. 
Romanello,V., Guadagnin,E., Gomes,L., Roder,I., Sandri,C., Petersen,Y., Milan,G., Masiero,E., 
Del,P.P., Foretz,M., Scorrano,L., Rudolf,R., and Sandri,M. (2010). Mitochondrial fission and 
remodelling contributes to muscle atrophy. EMBO J 29, 1774-1785. 
Sandri,M., Lin,J.D., Handschin,C., Yang,W.L., Arany,Z.P., Lecker,S.H., Goldberg,A.L., and 
Spiegelman,B.M. (2006). PGC-1 alpha a protects skeletal muscle from atrophy by suppressing 
Fox03 action and atrophy-specific gene transcription. Proceedings of the National Academy of 
Sciences of the United States of America 103, 16260-16265. 
Santel,A., Frank,S., Gaume,B., Herrler,M., Youle,R.J., and Fuller,M.T. (2003). Mitofusin-1 protein 
is a generally expressed mediator of mitochondrial fusion in mammalian cells. J. Cell Sci. 116, 
2763-2774. 
Schagger,H. (1995). Native electrophoresis for isolation of mitochondrial oxidative 
phosphorylation protein complexes. Methods Enzymol. 260, 190-202. 
Scorrano,L., Ashiya,M., Buttle,K., Weiler,S., Oakes,S.A., Mannella,C.A., and Korsmeyer,S.J. (2002). 
A Distinct Pathway Remodels Mitochondrial Cristae and Mobilizes Cytochrome c during 
Apoptosis. Dev. Cell 2, 55-67. 
Seo,A.Y., Joseph,A.M., Dutta,D., Hwang,J.C.Y., Aris,J.P., and Leeuwenburgh,C. (2010). New 
insights into the role of mitochondria in aging: mitochondrial dynamics and more. Journal of Cell 
Science 123, 2533-2542. 
113 
 
Sun,M.G., Williams,J., Munoz-Pinedo,C., Perkins,G.A., Brown,J.M., Ellisman,M.H., Green,D.R., and 
Frey,T.G. (2007). Correlated three-dimensional light and electron microscopy reveals 
transformation of mitochondria during apoptosis. Nat. Cell Biol. 9, 1057-1065. 
Wang,X. (2001). The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922-2933. 
Wang,Z.G., Jiang,H., Chen,S., Du,F.H., and Wang,X.D. (2012). The Mitochondrial Phosphatase 
PGAM5 Functions at the Convergence Point of Multiple Necrotic Death Pathways. Cell 148, 228-
243. 
Wasilewski,M. and Scorrano,L. (2009). The changing shape of mitochondrial apoptosis. Trends 
Endocrinol. Metab 20, 287-294. 
Wei,M.C., Lindsten,T., Mootha,V.K., Weiler,S., Gross,A., Ashiya,M., Thompson,C.B., and 
Korsmeyer,S.J. (2000). tBID, a membrane-targeted death ligand, oligomerizes BAK to release 
cytochrome c. Genes Dev. 14, 2060-2071. 
Wei,M.C., Zong,W.X., Cheng,E.H., Lindsten,T., Panoutsakopoulou,V., Ross,A.J., Roth,K.A., 
MacGregor,G.R., Thompson,C.B., and Korsmeyer,S.J. (2001). Proapoptotic BAX and BAK: a 
requisite gateway to mitochondrial dysfunction and death. Science 292, 727-730. 
Yamaguchi,R., Lartigue,L., Perkins,G., Scott,R.T., Dixit,A., Kushnareva,Y., Kuwana,T., 
Ellisman,M.H., and Newmeyer,D.D. (2008). Opa1-mediated cristae opening is Bax/Bak and BH3 
dependent, required for apoptosis, and independent of Bak oligomerization. Mol. Cell 31, 557-
569. 
Yin,X.M., Wang,K., Gross,A., Zhao,Y., Zinkel,S., Klocke,B., Roth,K.A., and Korsmeyer,S.J. (1999). 
Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400, 886-891. 
Zhang,Z.Y., Wakabayashi,N., Wakabayashi,J., Tamura,Y., Song,W.J., Sereda,S., Clerc,P., 
Polster,B.M., Aja,S.M., Pletnikov,M.V., Kensler,T.W., Shirihai,O.S., Iijima,M., Hussain,M.A., and 
Sesaki,H. (2011). The dynamin-related GTPase Opa1 is required for glucose-stimulated ATP 
production in pancreatic beta cells. Molecular Biology of the Cell 22, 2235-2245. 
 
 
 
 
 
 
 
 
 
114 
 
The multifunctional mitochondrial inner membrane protein Optic 
Atrophy 1 controls cellular damage in vivo 
Tatiana Varanita, M.E. Soriano Garcìa Cuerva, Vanina Romanello, Tania Zaglia, 
Roberta Menabò,  Veronica Costa, Sara Cogliati, Ruth Slack, Marco Mongillo, 
Marco Sandri, Fabio Di Lisa, and Luca Scorrano 
 
Supplementary online material 
Legends to supplementary figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
115 
 
 
Supplementary Figure 1S. Characterization of Opa1tg mice 
(A) Equal amounts of protein from liver tissue of the indicated genotypes were 
separated by SDS-PAGE and immunoblotted with the indicated antibodies.  
(B) Equal amounts of protein from liver tissue of the indicated genotypes were 
separated by SDS-PAGE and immunoblotted with the indicated antibodies.  
(C) Growth rate of  C57/Bl6 Wt and Opa1tg males and females during the initial 60 
days of life. Data  represent  average + SEM (n=20 per each group). 
(D) Body weight is represented as average + SEM of 5 months males (n=17 for each 
group) and females (n= 10 for each group) and 9 months old males (n= 19 for each 
group) and females (n=8 for each group) SV129 Opa1tg  and Wt litettermates.  
 
Supplementary Figure 2S. Histological and morphological characterization of 
heart, liver and kidney 
(A) Immunofluorescence analysis on ventricular cryosections from Wt and Opa1tg  
mice stained with an antibody to dystrophin. Images are details from the left 
ventricle.  
(B) Evaluation of cardiomyocyte (CM) area in cryosections from Wt and Opa1tg 5 
months old hearts. Bars indicate average + SEM. (n=5 for each group).  
(C) Echocardiographic long axis view of hearts from  5 months old Wt and Opa1tg 
littermates. LV: left ventricle; A: aorta.  
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(D) Haematoxilin-eosin staining in ventricular cryosections from 5 months Wt and 
Opa1tg  mice.  
(E) Immunofluorescence analysis of heart cryosections from 9 months old  Wt and 
Opa1tg mice stained with an antibody to Collagene I (Col.I).  
(F) Evaluation of liver weight/body weight ratio in  5 and 9 months old male mice. 
Wt and Opa1tg . Bars indicate average + SEM (n=10 for each group). 
(G) Echographic view of the liver from 9 months old Wt and Opa1tg mice.  
(H) Echographic short axis view of the left kidney from  9 months old Wt and 
Opa1tg mice.  
(I) Morphometric analysis of kidney from 9 months old Wt and Opa1tg mice. Error 
bars indicate s.e.m. (n=6 for each group). 
 
Suplimentary Figure 3S. Opa1tg mitochondria are slightly elongated and contain 
tighter cristae 
(A) Complex IV dependent respiration of mitochondria isolated from livers of the 
indicated genotypes. Data represent  average + SEM (n=4 for each group).  
(B) Representative traces of Calcium Retention Capacity (CRC) of liver 
mitochondria isolated from 5 months old Wt and Opa1tg mice. Where indicated, 2 
µM CsA was present in the mediumCsA.  
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(C) Quantification of CRC in experiments as in (D).  
(D) Representative traces of Rhodamine 123 fluorescence. Mitochondria isolated 
from livers of the indicated genotype (1 mg/mL, MLM) were treated where 
indicated (arrows) with 300 µM ADP and 200 nM FCCP.  
(E) Mitochondria of the indicated genotype were treated with cBID for the 
indicated times. 10 mM BMH or DMSO was then added and after 30 min the 
proteins were analyzed by SDS-PAGE/immunoblotting using anti-BAK antibody. 
Asterisks indicates BAK multimers. 
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5 Conclusions and perspectives 
In this thesis we addressed the role of OPA1 overexpression in the tissue response 
to damage in vivo. We used a mouse model with a specific targeted insertion that 
resulted in OPA1 ubiquitous mild overexpression in a variety of tissues. Our data 
indicate that a slight increase of OPA1 is sufficient to improve the response to 
several death stimuli.  
Increased levels of OPA1 can retrogradely inhibit the program of muscular atrophy 
induced by denervation due to the maintenance of functional mitochondria. In 
addition Opa1tg mice were resistant to brain ischemia, cardiac 
ischemia/reperfusion and Fas mediated hepatocellular apoptosis. We 
biochemically elucidated the mechanism behind this protective effect of OPA1 
overexpression. Increased OPA1 levels resulted in an augmented OPA1 
oligomerization, which is known to correlate with the maintenance of cristae 
tightness and with the prevention of cytochrome c mobilization.  
Fibroblasts derived from Opa1tg mice have been used to dissect the role of cristae 
shape in mitochondrial bioenergetics. Acute ablation of Opa1 resulted in aberrant 
cristae morphology, reduced RCS assembly and impaired complex I dependent 
respiration. On the other hand Opa1tg fibroblasts display an increase RCS assembly, 
respiratory function and cell growth. Opa1tg cells have been an useful tool to 
unveil how OPA1 regulates respiratory efficiency and we can predict that they will 
be useful also to address the molecular mechanism by which Opa1 overexpression 
protects for example from mitochondrial dysfunction. One tempting possibility is 
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that Opa1 and the so called permeability transition pore (PTP) crosstalk. The PTP is 
an IMM channel whose opening is associated with multiple forms of mitochondrial 
dysfunction and death, due to the collapse of the electrochemical gradient and to 
mitochondrial swelling. Interestingly, during mitochondrial cristae remodeling the 
PTP opens and it was recently discovered that dimers of the ATPase, that control 
cristae morphology, constitute the PTP. In a plausible scenario, Opa1 
overexpression could interfere with ATPase dimerization or even better with the 
binding of the PTP activator cyclophilin D to the ATPase dimers. Elucidating this 
mechanism could be of great impact to deploy a two pronged strategy of 
mitochondrial preservation for example in heart ischemia, where PTP inhibitors 
are already in Phase II clinical trials.  
Another interesting paradigm in which it is worth exploring whether Opa1 
overexpression can be beneficial is mitochondrial disorders, a group of clinical 
entities associated with defects of OXPHOS, most often partial (i.e., caused by a 
partial, above threshold depletion in one respiratory chain complex). It would be 
tempting to speculate that OPA1 overexpression could help in the context of these 
diseases by enhancing RCS, which increase the efficiency of electron flow among 
complexes as well as individual complex stability. Since the mild overexpression of 
OPA1 is sufficient to ameliorate cristae morphology and consequently 
mitochondrial bioenergetics, we have already set out to investigate this possibility 
and we bred Opa1tg mice with a mouse model of OXPHOS deficiency. A muscle 
specific COX15 knockout mouse recapitulates the clinical manifestation of several 
complex IV deficiency, displaying a severe atrophic phenotype, heavily reduced 
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running performance and dying before it reaches 6 months of age (Viscomi et al 
2011). Interestingly, our preliminary results indicate that the mild overexpression 
of OPA1 is sufficient to ameliorate every aspects of this pathological phenotype. 
This model further supports the role of OPA1 in RCS stabilization and it open new 
therapeutic perspectives in the treatment of mitochondrial diseases characterized 
by impairment of mitochondrial bioenergetics. 
Our studies allow to conclude that Opa1-dependent cristae remodeling and 
biogenesis may be exploited to treat not only primary mitochondrial disorders, but 
also sporadic pathological conditions that are widespread in an aging society such 
as heart ischemia, stroke and muscular atrophy.  
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